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The current obesity epidemic has become a major health crisis to citizens around the 
United States.  Obesity has been successfully linked to a plethora of different disease states 
including cardiovascular disease, diabetes, and stroke.  Although many people might not 
recognize the trends, the obesity epidemic is putting children as young as 5 and 6 years of age at 
a health disadvantage compared to children of a healthier weight.  With 17% of American’s 
children being classified as obese, it is important to uncover what detrimental influences obesity 
has on the childhood body.     Specifically, with respect to bone health, there is a good amount 
of information supporting the concept that there is increased acquisition of bone mineral 
density (BMD) through exercise in children.  However, none of these studies have investigated 
the effects of physical exercise on BMD in obese children compared to lean children.  Previous 
studies show that overweight and obese children are at an increased risk of bone fracture due 
to low bone mass and bone area for weight.  An increased response in BMD or bone mineral 
content (BMC) of obese children due to exercise could improve bone strength and decrease 
 fracture risk.  The purpose of this study was to investigate whether there were differences in 
BMD acquisition in lean and obese children in response to a 16-week exercise intervention.  
Dual energy X-absorptiometry (DEXA) was used to assess the change in BMD in children at week 
0 and 16.  Participants were grouped by body mass index percentile as obese (n=41) or lean 
(n=19) and then randomly assigned to exercise or control groups.  The exercise protocol 
consisted of aerobic activities such as running, basketball, tennis, football, etc.  Participants 
were required to meet a heart rate average of >140 beats per minute each one-hour exercise 
session.  The protocol for the study was reviewed and approved by the East Carolina University 
Institutional Review Board.  Both lean and obese exercise groups increased total body bone 
mineral density (+0.026±0.001g/cm2, +0.028±0.001g/cm2 respectively; p<0.05) from week 0 to 
16.  Total body BMC also increased in the lean and obese (+111± 4.4g, +106±4.3g respectively; 
p<0.05) exercise groups.  There were no significant increases in BMD in controls groups.  The 
increases in BMD and BMC of the exercise groups, suggests that bone metabolism responded 
similarly in both treatment groups.  The results advocate that there is no difference in bone 
acquisition of lean and obese prepubescent children of different BMI percentiles. 
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Chapter 1: Introduction 
 With recent budget cuts across the nation, schools have been forced to cut back on 
resource classes such as physical education, in order to save money.  The elimination of 
physical education classes has a detrimental effect on the growing childhood obesity 
population; depriving children of physical activity over an eight hour day could have an additive 
negative effect on children’s ability to grow strong and healthy bones.   Incidence of bone 
fracture is remarkably high in childhood as well as in adolescence.  For this reason attaining 
peak bone mass in childhood is very important in prevention of fractures, as well as other bone 
diseases throughout life.  It is theorized that every individual has a brief window during 
childhood, specifically puberty, to reach peak bone mass.  Bone fractures in childhood can add 
to the healthcare cost of families so it is important for families and healthcare providers to 
understand what type of childhood exercise can be beneficial to build bone mass in children.  
Peak bone mass can provide additive protection from diseases such as osteoporosis, and 
osteopenia, which normally arise at older ages (Kanis, John 1994; Rutherford, M. 1999).  
Recently it has been reported that the incidence of fracture has increased 30 percent in 
adolescent populations over the last 30 years (Kanis, John A. 1994).  Though it is not completely 
understood as to what sparked such a dramatic increase in fractures among this specific 
population, it is certain that there is an increased incidence of obesity in children, and 
decreased activity patterns over the same 30-year time span (Ogden CL 2006; Ogden CL 2008).  
It is paramount to understand the mechanisms that drive the body to create bone so that 
proper preventive steps can be followed in order to reduce the risk of costly bone fractures and 
disease’s.  
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Hormonal factors, diet, and exercise have all been proven to affect biological processes 
that can manipulate bone metabolism.  Many studies have been designed to investigate how 
these different factors manipulate bone development (L. H. Foo 2008; Bass,S. 1998).  With 
regards to hormonal influences, it is unclear the exact mechanism to which hormones can 
increase bone density.  Hormones such as parathyroid hormone, growth hormone, and vitamin 
D can contribute to osteoblast and osteoclast activity in the bones; however, more knowledge 
is needed before adequate recommendations can be made regarding the manipulation of these 
hormones to gain peak mass.  Load bearing exercises, along with a diet supplemented with 
calcium have both been proven to increase bone mineral density. Load bearing activities such 
as running and jumping as few as 3 days a week have been shown to increase bone mineral 
density in boys and girls ( Hind, K. 2007; MacKelvie, K J. 2002).  
  Load bearing activities can have a positive influence on bone mineral density, however 
it is not as clear at what age bone mineral density can increase most readily.  There is also some 
debate on whether children with more mass can derive skeletal benefits from constant weight 
bearing compared to individuals with less mass.  Prior studies have shown that obese children 
have increased bone mass compared to healthy normal children (Leonard, Mary B. 2004; 
Manzoni, P. 1996;), while others suggest a low bone mass to body weight ratio exists in obese 
children (Goulding, A. 2000, Goulding,A.2001).  Goulding et al believed that if obese individuals 
display a low bone mass to body weight ratio, which would indicate structural instability.  This 
instability would lead to a greater incidence of bone fracture because these children would be 
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carrying more loads compared to lean children.   With conflicting evidence, there is still 
uncertainty as to if obese children have stronger bones compared to lean children. 
   The prepubertal stage of life represents a period of time where sex hormones such as 
testosterone and estrogen are found in lower concentrations than during and after puberty.  
The lack of steroids has led many investigators to believe that children are unable to produce 
adequate gains in bone density during the prepubertal years, whereas increases in bone 
mineralization during puberty can be far more superior.  Sex hormones such as testosterone 
and estrogen can have an anabolic effect towards skeletal growth in children going through 
puberty (Behre, Hermann M. 1997).  Growth hormone, Insulin like growth factor, parathyroid 
hormone, and vitamin D, are believed to contribute greatly to increases in bone mineral density 
in those children who have yet to reach puberty (Bass, S. 1998).   
Purpose 
 Current literature lacks comprehensive data on how exercise can change bone mineral 
density in lean and obese prepubescent children.   A study of exercise training, specifically in 
lean and obese children, could give a unique opportunity to understand how everyday 
activities, such as basketball, football, running, etc. can influence bone metabolism in children 
of two different weight categories.  The current study examined the effects of a 16-week 
physical activity intervention program on bone mineral density in lean and obese prepubescent 
children ages 8-11.  Furthermore, a sedentary lean and obese control group was used to 
determine if exercise had an effect.   
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Hypotheses 
 Based on the current and previous literature as well as pilot data seen in Figure 1 and 
Figure 2 below, I hypothesized that:  bone mineral density would increase in the prepubescent 
lean children involved with the exercise intervention group when compared to the lean 
sedentary control group.  Likewise, the prepubescent obese group would increase bone mineral 
density regardless of group. 
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Pilot Figure 1: 
 
Fig1:  Pilot data obtained from ongoing research suggested that a  lean 16 week 
exercise (n=10)  group had a greater gain in total body bone mineral density, when compared 
to a lean, sedentary, 16 week control (n=7) group.   
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Pilot Figure 2:  
  
Figure 2:  Pilot data obtained from obese 16 week exercise (Group 1, n=15) and non-
exercise (Group 2, n=8) groups suggested that both groups increase BMD values regardless of 
exercise.    
 
Aim of the research: 
1.  To determine if there was an increase in total body bone mineral density and bone 
mineral content due to a 16 week exercise program in lean and obese prepubescent children.   
To accomplish this, bone mineral density was scanned using dual energy X-ray Absorptiometry 
before and after 16 weeks of either the exercise intervention (treatment groups) or a 
corresponding 16 weeks without intervention (control group) .  
Sub-Aims (Confounders of Bone Health in Children)  
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Sub aims were used to report supplemental data known to influence bone metabolism 
in prepubescent children.  These sub-aims specifically report activity and dietary data collected 
from all participants.   
1.  Activity (steps) was monitored and reported as a 3-day step count average for all 
groups at weeks 0, 4, 8, 12, and 16.  To accomplish this, activity monitors were worn by all 
participants every four weeks over the 16 week intervention.   
2.  Dietary information was monitored to determine if children were reaching 
recommended dietary allowances (RDA) for calcium (1300mg), phosphorus (1250mg), and 
adequate intake (AI) for vitamin D (5ug).  This was accomplished by entering 3-day food records 
into a nutritional analysis program every four weeks over the 16 week intervention.    
Limitations: 
Limitations of the current study could include, but are not limited to, the following:  1. 
when recruiting potential subjects, physical activity is a major determinant of the child’s 
acceptance into the program.  Being that only sedentary children are recruited, it is possible 
that the parents misconstrue the amount of physical activity the child actually gets so that they 
will be able to participate.  2.  Without a controlled diet during the 16-week period, some 
participants could be receiving a greater amount of calcium and vitamin D, this ultimately could 
influence bone metabolism.  3.  Limitation exists with the Dual energy X-ray absorptiometry 
when taking scans on children.  Bone mineral density is often overestimated in smaller 
individuals.  
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Delimitations: 
Delimitations found in the design of the current study include, but are not limited to, 
the following:  1. Only African American and Caucasian children are allowed to be participants.  
2.  Subjects involved with the exercise group are either classified as being lean or obese 
according to the CDC growth charts.  3.  Recommendations generated from results are specific 
to children 8-11 years of age.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Chapter 2: Literature Review 
Bone Mineral Density and Physical Activity.   
Bone mineral density has been shown to increase through exercise, regardless of age 
and gender.  While there is some scrutiny on the exact mechanism of how this increase occurs, 
there is evidence that a positive correlation does exist between the two factors.  As shown 
throughout numerous experimental studies, increases of bone mineral density can be 
maximized through load bearing activities such as resistance training. (Bass, S. 1998; Hind, K. 
2007).  Although load bearing activities seem to be the “gold standard” with respect to bone 
mass increases, there is evidence that aerobic activities such as walking, running and school 
physical education programs designed for children can prevent bone loss, and even increase 
the body’s ability to synthesize bone at specific sites ( MacKelvie, K J. 2002; MacKelvie, Kerry J. 
2004).  A few studies have been conducted to examine the effects of long term, longitudinal 
physical activity programs on bone mass (Bailey, D.A. 1999). While these particular studies 
provide good evidence of the effects of physical activity on bone density, it is still unclear as to 
what intensity an aerobic exercise protocol must be in order to entice the body to create more 
bone.    Another key contributor to the mineralization of bone with regards to exercise is 
hormonal factors.  Hormones such as growth hormone (GH), parathyroid hormone (PTH), 
insulin-like growth factor (IGF), and vitamin D all play an important role in the bone creation 
process.  It has been observed that sedentary individuals can increase circulating levels of 
particular hormones (PTH) by simply exercising for 3 days, 30- 40 minutes a day at 50%of their 
VO2max ( Thorsen K 1997).  
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Age and Bone Mineral Density   
Peak bone mass is very important to achieve with regards to preventing any type of 
bone fractures throughout life.   Although with some controversy it has been suggested that 
children begin to build most of their bone mass by the age of 8 years old, and continue through 
adolescence.  Many researchers believe that if a high bone density can be obtained successfully 
in younger years, it is likely to have a protective effect on bone fracture rate, and bone diseases 
such as Osteoporosis and Osteopenia (Kanis, John A. 1994; Rutherford, O M. 1999; Thorsen K 
1997).  While there is hard evidence that physical activity can increase bone mineral density in 
children involved with weight bearing physical activities, such as the ones provided in the 
physical education classrooms in school, the researchers debate at what age bone can most 
readily be manipulated to receive maximal bone density from such activities.  The debate stems 
from the fact that young children, that have yet to reach puberty, don’t have sufficient ability to 
synthesize hormones needed to properly build bone.  It is believed by some researchers that 
puberty marks the stages of increase bone accrual, for the simple fact that levels of hormones 
specific to bone metabolism increase at puberty, and this allows the bones to calcify more 
readily.  It has also been shown that growing children have a better ability to absorb calcium 
through dietary means when compared to adults (Sareen G. 2007).  This higher calcium 
absorption in children than adults could possibly explain why peak bone mass can be obtained 
throughout growing years.  
Calcium  
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From muscle contractions to blood clotting calcium serves an important function in 
various biological systems throughout the body.  Calcium is very important in children when it 
comes to their ability to build strong bones.  If blood calcium levels are low in children the body 
will use calcium stores (bone) in order to meet its own needs, thus decreasing the amount of 
calcification that can occur in the bones.  With this in mind researchers have been trying to 
determine what variables can potentially increase calcium levels in the blood, while at the same 
time increasing bone absorption of this extra calcium.  Exercise has long been associated with 
its influence to help facilitate movement of calcium into the bone for absorption.   Load bearing 
activities seem to gain most of the recognition for maximal increases in bone mineral density.  
While it is good to have load bearing types of activities for adults, who have already attained 
maximal bone growth, some investigators are worried about the negative effects improperly 
performed load bearing activities can have on growing children.  In order to eliminate the 
possibility of injury in children due to load bearing activities it has been shown that increases in 
bone mineral density can be attained in children performing daily aerobic exercise routines that 
incorporate some level of low impact load bearing activity such as jumping.  Studies have 
shown increases of BMD from school physical education programs that have implemented 
aerobic jumping routines into their curriculum (Hind, K. 2007; MacKelvie, Kerry J. 2004). Other 
studies have tried to detect how blood biomarkers such as calcium and parathyroid hormone 
change in the presence of different types of exercise protocols, and exercise intensities. From 
these studies it has been shown that serum calcium levels can increase slightly during aerobic 
exercise in road cyclists, while parathyroid hormones increase significantly.    
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Tanner Stage and Bone Mineral Density         
Not all children grow and physically develop at the same rate, thus limitations exist in 
any study designed to understand what effect maturation has on children.  In order to 
successfully categorize children the Tanner scale of physical development is used.  This scale is 
useful when grouping males and females into similar groups according to sex specific traits.    
The Tanner scale is a way to classify what stage of puberty a particular participant falls into, this 
can sometimes be misinterpreted due to the ambiguity of measurement methods.    With 
regards to bone mineral density, the Tanner scale can be useful when determining a 
participant’s stage of puberty.  
Obesity and Bone Mineral Density 
Childhood obesity carries an increased risk of contracting diseases such as diabetes, 
dyslipidemia, and hypertension.  Obesity can promote a cascade of altered biological processes, 
as seen with Type 2 diabetes, so the likelihood that obesity can have a negative impact on bone 
formation cannot be ignored.   It has been shown that overweight and obese children have 
lower bone mineral content and bone area when compared to their normal weight peers 
(Goulding, A. 2000).  It has been theorized that adipocycte’s can collect within the bone 
alongside bone marrow in overweight and obese individuals.  This increase in adipocytes within 
the bone can prevent osteoblast production, and without proper osteoblast production, bone 
can become weak and thin.  Findings such as these could suggest that obese children are at a 
metabolic disadvantage in their ability to reach their maximum potential at forming bone.  
Obese individuals seem to have a decreased ability to synthesize some hormones.  Specifically 
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growth hormone, and insulin-like growth factor I, have been shown to be decreased in obese 
individuals when compared to lean counterparts.  Kanaley et el. has shown that growth 
hormone was suppressed in obese individuals during aerobic exercise, while non-obese 
participants could significantly increase growth hormone secretion during an aerobic bout of 
exercise  (Kanaley J A, 1997).  Results such as these continue to suggest that obese individuals 
are structurally limited with regards to bone integrity given the data that supports growth 
hormones positive effect on bone formation. Suppression of hormones such as growth 
hormone, in obese children, could be one reason why an obese population could be at risk of 
not reaching maximal bone mineralization.  
Hormonal Influences on Bone Mineral Density   
Several studies have investigated how different hormonal biomarkers can be affected by 
physical activity.  Vitamin D, also known as cacitriol, 1, 25-hydroxyvitamin D (25[OH] D), in its 
active form is a major contributor to bone metabolism.  When in the blood, cacitriol works with 
parathyroid hormone to control serum calcium levels.  If concentrations of calcium are low in 
the blood, parathyroid hormone is activated and signals are sent to the kidneys and intestinal 
cells to begin the process of absorbing calcium from the urine or food, cacitriol absorbs the 
food from the digestive track.   If blood calcium concentrations are found to be too high, 
calcitonin, another hormone that regulates bone metabolism, is secreted from parafollicular 
cells of the thyroid to aid in the mineralization of calcium into the bones.  Vitamin D, calcitonin, 
and parathyroid hormone act on different bone cells that can build bone or break down bone 
such as osteoblasts and osteoclasts. Primarily these hormones are used when calcium is found 
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in low or high concentration.  Osteoblasts are bone cells that increase the mineralization 
process, Osteoclast’s are therefore the opposite in that they aid in the breakdown of bone so 
that calcium can be used for other bodily processes in times of inadequate supplementation.   
Parathyroid Hormone and Bone 
Parathyroid hormone (PTH) is secreted by the parathyroid gland, and is of large 
importance to bone building processes found throughout the body.  PTH has influence on the 
kidneys and the bones; it is a major regulator of calcium concentrations through out the body.  
When the concentrations of calcium decrease in extracellular fluid, PTH will send signals to the 
bone, and the kidneys to increase bodily resorption of calcium.  Bone resorption occurs by 
increasing activation of osteoclasts found in the bone, which in turn aid in breaking down 
calcium stores and releasing this calcium into the extracellular fluid so that concentrations can 
return to normal levels.  In the kidneys, PTH works to retain calcium via the kidney tubules.  
Once signaling begins, the kidney acts to prevent calcium from being lost during urination, thus 
the body can actively recycle its own calcium.  It is hypothesized that PTH can act directly on 
local growth factors found in the bone.  Insulin-like growth factor is thought to work directly 
with PTH to stimulate bone formation, although the exact mechanism for this process is still 
being assessed (Wuster C 1993; Yakar S, 2002).  Studies involved with parathyroid 
supplementation have successfully determined that supplementation can increase bone 
mineral density of the spine, hip and total-body bone mineral.  
Growth Hormone and Bone Metabolism 
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Growth hormone is secreted from the pituitary gland, and is instrumental in the bodies’ 
ability to stimulate growth and cellular reproduction; in its natural form, growth hormone is 
also referred to as somatotropin.  Due to its anabolic properties, growth hormone is believed to 
create a signaling cascade involving insulin-like growth factor (IGF-1) to increase osteoblast 
activity which in turn can increase bone growth.  While this process is a secondary, or indirect 
effect of growth hormone, its secretion is needed in order to fully accommodate bodily 
processes that use growth hormone for stimulation.  Growth hormone secretion can be 
influenced by a variety of different factors.  Stress, nutrition, exercise and sleep can all have an 
influence on the secretion patterns of this hormone.  Growth hormone is secreted from the 
anterior pituitary gland; it is regulated primarily by hormones that are secreted from the 
hypothalamus and the stomach.  Using a negative feedback loop with IGF-1, growth hormone is 
signaled to be secreted when blood levels of IGF-1 fall.  Once growth hormone increases in the 
blood, the liver will begin to process more IGF-1 to be circulated to target tissues.  It has been 
seen that obese individuals have lower secretion rates of growth hormone compared to lean 
peers (Scacchi, M. 1999).  Using mathematical formulas, Iranmanesh et al. determined that GH 
secretion rate can be decreased by 6% for every body mass index (BMI) unit increase.  Exercise 
training bouts have been shown to increase growth hormone secretion in non-obese individuals 
when compared to obese individuals (Iranmanesh A. 1991).   This decrease in release of GH 
could be one of the factors that limit obese children from being able to increase bone mineral 
density, when compared to lean children.   
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IGF-1 and Bone Metabolism 
Insulin-like growth factor 1 has been recognized as a facilitator for stimulation and 
growth of many cellular processes.  Increase in the size of muscle and bone are directly related 
to increased levels of IGF-1.    Produced in the liver, IGF-1 helps to regulate the amount of 
growth hormone found in the blood stream, if GH is being inhibited due to some metabolic 
abnormality, such as found in obese individuals, it is likely that IGF-1 will be found in minimal 
concentrations due to the impaired releasing mechanism.  Studies on osteoporotic patients 
have determined that lower concentrations of IGF-1 can play a big part in the weakening of 
bones.   Wuster et al. showed that IGF concentrations were decreased in patients suffering 
from osteoporosis (WÜSTER,C. 1993).  In prepubescent children IGF-1 plays an important role in 
facilitating longitudinal growth.  Dwarfism can result in the case where an individual cannot 
biologically create ample amounts of IGF (Laron syndrome).  It has also been discovered that 
knockout mice, which have been deprived of the IGF-1 gene have reduced skeletal 
development as well as reduced growth patterns (Yakar S 2002).   It is certain that IGF-1 plays 
an important role in regulating cellular processes; it is less certain how an intervention such as 
exercise could inhibit or increase concentrations in children.  As seen in previous studies it is 
clear that GH can be increased through exercise, this increase could indirectly facilitate 
increases of IGF-1, but lab testing would be needed to confirm this suspicion.   
3 Day Food Records 
Self-reported food records have been determined to be an accurate and inexpensive 
method to asses nutrient intake.  With regards to children, these records have been shown to 
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be a very good measure of nutritional status (Domel, S B 1994).  Children as young as eight 
years old have been reported to maintain accurate food records over a 3 day period (Crawford 
1994; Livingstone 2000).   
Calcium Intake  
The increase in soft drink usage among all populations has created concern for whether 
children and adults are consuming enough calcium products such as milk in their daily diets.  
Fleming et al. reported that a large proportion of the U.S. population is receiving substantially 
less calcium than what RDA requirements have suggested  (Fleming,  Heimbach 1994).  Current 
NHANES III data has supplemented those claims while investigating the trends of dietary intake 
in the United States.   It was reported that in the year 2000 only 30% of population ages 2 and 
older were receiving the recommended amount of calcium (Briefel , Johnson 2004).   
Phosphorus Intake  
Phosphorus intake in children has stayed about the same among the United States 
population over the past 30 years (Enns, C.W 2002).  Phosphorus in the diet can be obtained 
from a variety of sources including milk, yogurt, cheese and tuna.  With the consumption of 
milk down over the past 10 years, it has been shown that soft drinks are providing a good 
majority of the dietary phosphorus being consumed in the United States.  In fact soft drink 
consumption has increased 48% from the time span of 1978-1998 (French 2003).  This dramatic 
increase in soft drink consumption supports the idea that soft drink consumption has surpassed 
consumption of milk.   
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Vitamin D Intake  
The adequate intake for vitamin D is set at 5 international units per day.  According to 
nationally represented data such as the Third National Health and Nutrition Examination 
Survey, and the Continuing Survey of Food Intakes report that vitamin D dietary intake has 
stayed within recommended levels over the past thirty years (Moore 2004).  It is believed that 
fortification of foods such as cereal, breads, and milk help children reach the adequate levels.    
 
 
 
 
 
 
 
 
 
 
 
 
  
Chapter 3 Methods 
Methods 
The data from this study was obtained in cooperation with a current ongoing study 
being conducted at East Carolina University.  All methods are approved by the East Carolina 
University Institute Review Board.   
Participants 
Sixty healthy children ages 8-11 were recruited from the Pitt County School Systems.  A 
flyer was sent to the schools and handed out to grades 3, 4, and 5.  Participants were screened 
over the phone with a questionnaire to ensure that they are currently sedentary and not 
involved in any type regular physical activity (i.e. gymnastics, football, basketball).  Participants 
were excluded from the study if they fell between the 80th- 95th BMI percentiles for age, if they 
were too physically active, or if they were currently taking medications that could affect central 
or peripheral circulation. Any participant who had prior medical history including diabetes, 
hypertension, congestive heart failure, angina, or peripheral vascular disease were also 
excluded from the study.   A Tanner Stage questionnaire was used in order to determine if the 
children were prepubescent, Tanner stage 1 or 2.  All participants were randomly assigned to 
either exercise or a sedentary control group.  Random assignment was determined using a 
computer-based random number generator.  Participants assigned to the experimental group 
exercised for a 16-week period.    Participants assigned to the non-exercise group, followed the 
same testing protocol.   
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Procedures 
Following recruitment, an initial meeting was scheduled with both the child and the 
parent.  During this initial meeting, parameters of the study and any risks that might be 
involved with participation were explained to the participants.  The child and parent both 
signed a consent and child assent before beginning any participation into the study.  A medical 
history form was given to the parents to fill out in order to screen for any medications, or 
illnesses the child has experienced.   Initial testing of body composition and VO2 performance 
were assessed in two later meetings.  Exercise and non-exercise groups performed activities 
according to their respective groups. After the sixteen week period a final body composition 
was performed.    
Training Protocol 
Over the 16 week period participants exercised for three days a week for an hour each 
session.  An average heart rate minimum of 140 beats per minute was obtained for each one 
hour exercise session.  Exercise was performed on the campus of East Carolina University. All 
exercise was supervised by either a graduate student or exercise physiology undergraduate 
student.  Activities were based on preference of the participant; aerobic activities such as 
running, basketball, tennis, football, etc. will be used to maintain proper heart rate.  The heart 
rate of >140 beats per minute, was set from a 65% of heart rate max.      
Testing 
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At the beginning of the study all participants were tested via a DEXA scan in order to 
obtain total bone mineral content values.    After 16 weeks of intervention, all participants 
perform another DEXA scan.   
Activity Monitoring 
Activity patterns were measured at 4-week intervals throughout the 16-week study 
using a Yamax pedometer (Yamax, Japan) and a CSA accelerometer (Computer Science 
Applications, Inc.).  Both groups received activity monitors 5 days prior to beginning of any 
intervention.  These accelerometers and pedometers were worn for three week days (i.e. 
Wednesday, Thursday, and Friday) as well as for the weekend prior to starting intervention.  In 
order to track activity during the 16 week program, children took home accelerometers and 
pedometers every four weeks (week 4, 8, 12); at this time children wore accelerometers and 
pedometers for 3 days (a program, non-program, and weekend day).  On week 16 children 
again took home an accelerometer and pedometer for a final time, in which they wore it for 
five days, as performed on their pre-intervention week.   
Nutritional Monitoring  
A diet recall was used to track calcium intake levels among participants.  When children 
picked up activity monitors they also took home a 5-day (pre and post weeks), or 3-day (weeks 
4, 8, 12) diet log.  Children recorded everything they ate during these days.  The days recorded 
corresponded with the day’s activity monitors were worn.  The children were given examples of 
how to complete dietary logs and were shown how to record proper measurements of food 
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intake.  Parents were also shown all dietary information and were tutored on the importance of 
measurement collection.  Upon completing diet logs and activity monitoring, records were 
reviewed with the child and parent to ensure greater accuracy.  Nutritionist Pro was used for 
analysis of dietary intakes.   
Statistics 
 A student T-test will be used to compare the means for BMD and BMC of lean 
treatment, lean control, obese treatment, and obese control from pretest to post test.  2 way 
repeated measures ANOVA will be used to test the difference between the groups (lean versus 
obese treatment) with respect to BMD and BMC values at pre and post testing.  Significance will 
be accepted at the p<0.05. 
 
 
 
 
 
 
 
 
 
 
 
 
  
Chapter 4: Results 
Descriptive characteristics of both obese and lean participants are shown in table 1 as 
the mean plus or minus the standard deviation.  The samples included in this study include 11 
lean treatment participants, 8 lean control participants, 29 obese treatment participants, and 
12 obese control participants.  Unless otherwise noted all graphs are reported as the mean ± 
SEE.   
Table 1: Descriptive Statistics (All Subjects) 
Note:  Children >95
th
 percentile according to BMI are classified as obese.  Children <80
th
 percentile 
are classified as lean.  Reported as mean plus or minus the standard deviation 
 
Bone Mineral Density 
All participants performed a DEXA scan in the beginning and at the end of 16 weeks.  
Table 2 shows descriptive data of bone mineral density (g/cm2) of obese participants.  Table 2b. 
includes descriptive data of bone mineral density (g/cm2) of lean participants. 
 
 
 
 
 Lean Treatment 
(n=11) 
Lean Control  
(n=8) 
Obese 
Treatment 
(n=29) 
Obese Control 
(n=12) 
Age 9.0 ± 1.0 9.4 ± 1.2 9.7 ± 1.1 10.0 ± 1.1 
Weight (kg) 35.4 ± 5.9 34.6 ± 7.8 58.7 ± 11.8 54.0 ± 12.3 
Height (cm) 144.7 ± 8.8 144.3 ± 11.4 147.8 ± 7.0 146.0 ±6.4 
BMI % 51.9 ± 21.5 46.1 ± 24.3 97.0 ± 0.3 96.0 ± 2.3 
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Table 2a. Bone Mineral Density (Obese) 
 
Note:  Bone mineral density in (g/cm2) scan pre to post testing; * P<0.05 pre vs pos; Reported as the mean ± SEE 
 
Table 2b.: Bone Mineral Density (Lean) 
 
DEXA 
Scan 
 
 
Lean Treatment 
 
Percent 
Change 
 
 
Lean Control 
 
Percent 
Change  
 
TB 
(Pre|Post) 
 
0.9326±0.02 
 
0.958±0.02* 
 
+2.61% 
 
0.929±0.02 
 
0.942±0.02 
 
+1.38% 
Arms 
(Pre|Post) 
 
0.620±0.06 
 
0.677±0.02 
 
+8.42% 
 
0.682±0.02 
 
0.723±0.02* 
 
+5.67% 
Legs 
(Pre|Post) 
 
0.944±0.04 
 
0.985±0.04* 
 
+4.16% 
 
0.958±0.05 
 
0.982±0.04 
 
+2.44% 
Pelvis 
(Pre|Post) 
 
0.881±0.03 
 
0.891±0.03 
 
+1.12% 
 
0.876±0.03 
 
0.898±0.03 
 
+2.45% 
Spine 
(Pre|Post) 
 
0.723±0.02 
 
0.742±0.2* 
 
+2.56 
 
0.739±0.02 
 
0.746±0.02 
 
+0.94% 
       
Note:  Bone mineral density in (g/cm2)scan pre to post testing; * P<0.05 pre vs pos; Reported as the mean ± SEE 
 
DEXA 
Scan 
Obese Treatment 
 
Percent 
Change  
Obese Control Percent 
Change 
TB 
(Pre|Post) 
 
0.983±0.01 
 
1.01±0.15* 
 
+2.67% 
 
 
0.968±0.02 
 
0.984±0.03 
 
+1.63% 
Arms 
(Pre|Post) 
 
0.734±0.01 
 
0.752±0.01 
 
+2.39% 
 
0.730±0.02 
 
0.743±0.02 
 
+1.75% 
Legs 
(Pre|Post) 
 
1.071±0.02 
 
1.097±0.02* 
 
+2.37% 
 
1.075±0.04 
 
1.100±0.04* 
 
+2.27% 
Pelvis 
(Pre|Post) 
 
0.993±0.03 
 
1.023±0.02* 
 
+3.02% 
 
0.975±0.03 
 
1.010±0.04* 
 
+3.47% 
Spine 
(Pre|Post) 
 
0.846±0.02 
 
0.862±0.02* 
 
+1.86% 
 
0.823±0.03 
 
0.838±0.04 
 
+1.79% 
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Total Body Bone Mineral Density 
The change in total body bone mineral density (g/cm2) for the obese treatment group, 
from week zero to week sixteen is displayed below (Figure 1).  A student’s T test between the 
mean changes in bone mineral density shows a significant (P<0.001) increase from pre testing 
(0.982 ± .014 g/cm2) to post testing (1.01 ± 0.015 g/cm2).   
Figure 1 
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The change in total body bone mineral density (g/cm2) for the obese control group, from week 
zero to week sixteen is displayed below(Figure 2).  A student’s T test between the mean 
Figure 1 shows the change of Total Body BMD in the obese treatment group from pre to post 
testing.  N=29 
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changes in bone mineral density shows no significant (P>0.05) increase’s from pre testing 
(0.968 ± .029 g/cm2) to post testing (0.984 ± 0.030 g/cm2).   
 
Figure 2 
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The change in total body bone mineral density (g/cm2) for the all obese groups, from week zero 
to week sixteen is displayed below (Figure 3). 
 
 
Figure 3 
Figure 2 shows the change of Total Body BMD in the obese control group from pre to post 
testing.  N=12 
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The change in total body bone mineral density (g/cm2) for the lean treatment group, from week 
zero to week sixteen, is displayed below (Figure 4).  A student’s T test between the mean 
changes in bone mineral density shows a significant (P<0.01) increase from pre testing (0.932 ± 
.021 g/cm2) to post testing (0.958 ± 0.020 g/cm2).   
 
 
 
 
 
 
Figure 4 
Figure 3 shows the change of Total Body BMD in the obese treatment and control group at 
week 0 and 16. N= 29, OT; 12, OC 
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The change in total body bone mineral density (g/cm2) for the lean control group, from week 
zero to week sixteen is displayed below (Figure 5).  A student’s T test between the mean 
changes in bone mineral density shows no significant (P>0.05) increase’s from pre testing 
(0.930 ± .023 g/cm2) to post testing (0.942 ± 0.023 g/cm2).   
 
 
 
 
 
 
 
 
 
Figure 5  
Figure 4 shows the change of Total Body BMD in the lean treatment group from pre to post 
testing. N= 11 
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The change in total body bone mineral density (g/cm2) for the all lean groups, from week zero 
to week sixteen(Figure 6). 
Figure 6 
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Figure 5 shows the change of Total Body BMD in the lean control group from pre to post 
testing. N=8 
Figure six: The change of Total Body BMD in the lean treatment and control group at week 
0 and 16. N= 11, LT; 8, LC 
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Arm Bone Mineral Density 
The change in arm bone mineral density (g/cm2) for all lean groups, from pre to post 
testing is displayed below.  Treatment subjects had no significant (P>0.05) increase in bone 
mineral density from pre testing to post testing (Figure 7).  Control subjects significantly 
(P<0.05) increased arm BMD from pre testing (0.682±0.02 g/cm2) to post testing (0.723±0.02 
g/cm2). 
Figure 7 
 
 
Figure 7 displays the change in arm bone mineral density (g/cm
2
) for all lean groups, 
from pre to post testing. N= 11, LT; 8, LC 
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The change in arm bone mineral density (g/cm2) for all obese groups, from pre to post testing is 
displayed below (Figure 8).  Treatment and control groups did not significantly increase bone 
mineral density from pre testing to post testing.   
Figure 8 
 
Leg Bone Mineral Density 
The change in leg bone mineral density (g/cm2) for all lean groups, from pre to post 
testing, is displayed below.  Treatment subjects significantly (P<0.001) increased leg BMD from 
pre testing (0.944±0.04 g/cm2) to post testing (0.985±0.04 g/cm2) (Figure 9).  Control increased 
leg BMD from pre testing (0.958±0.05 g/cm2) to post testing (0.982±0.04 g/cm2).  
 
 
 
Figure 8 displays the change in arm bone mineral density (g/cm
2
) for all obese groups, 
from pre to post testing. N= 29, OT; 12, OC 
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Figure 9 
 
 
The change in leg bone mineral density (g/cm2) for all obese groups, from pre to post testing, is 
displayed below.  Treatment subjects significantly (P<0.001) increased leg BMD from pre testing 
(1.071±0.02 g/cm2) to post testing (1.097±0.2 g/cm2) (Figure 10).  Control subjects significantly 
(P<0.05) increased leg BMD from pre testing (1.075±0.05 g/cm2) to post testing (1.100±0.04 
g/cm2).  
 
 
 
 
 
 
 
Figure 9  displays the change in leg bone mineral density (g/cm
2
) for all lean groups, from 
pre to post testing. N= 11, LT; 8, LC 
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Figure 10 
 
 
Pelvis Bone Mineral Density 
The change in pelvis bone mineral density (g/cm2) for all lean groups, from pre to post 
testing, is displayed (Figure 11). Treatment subjects significantly (P>0.05) increased pelvis BMD 
from pre testing (0.881±0.03 g/cm2) to post testing (0.891±0.03 g/cm2) (Figure 11).  Control 
subjects significantly (P>0.05) increased leg BMD from pre testing (0.876±0.03 g/cm2) to post 
testing (0.898±0.03 g/cm2). 
 
 
 
 
 
Figure 10 displays the change in leg bone mineral density (g/cm
2
) for all obese groups, 
from pre to post testing. N= 29, OT; 12, OC 
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Figure 11 
 
 
The change in pelvis bone mineral density (g/cm2) for all obese groups, from pre to post testing, 
is displayed (Figure 12).  Treatment subjects significantly (P<0.001) increased pelvis BMD from 
pre testing (0.993±0.02 g/cm2) to post testing (1.023±0.02 g/cm2).  Control subjects 
significantly (P=<0.001) increased pelvis BMD from pre testing (0.975±0.03 g/cm2) to post 
testing (1.007±0.04 g/cm2). 
 
 
 
 
 
 
 
Figure 11 displays the change in pelvis bone mineral density (g/cm
2
) for all lean groups, 
from pre to post testing. N= 11, LT; 8, LC 
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Figure 12 
 
 
Spine Bone Mineral Density  
The change in spine bone mineral density (g/cm2) for all lean groups, from pre to post 
testing, is displayed (Figure 13).  Treatment subjects significantly (P<0.01) increased spine BMD 
from pre testing (0.723±0.02 g/cm2) to post testing (0.742±0.02 g/cm2).  Control subjects 
increased pelvis BMD from pre testing (0.739±0.03 g/cm2) to post testing (0.746±0.02 g/cm2). 
 
 
 
 
 
 
 
Figure 12 displays the change in pelvis bone mineral density (g/cm
2
) for all obese 
groups, from pre to post testing. N= 29, OT; 12, OC 
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Figure 13 
 
 
The change in spine bone mineral density (g/cm2) for all obese groups, from pre to post testing, 
is displayed (Figure 14).  Treatment subjects were able to significantly (P<0.01) increase spine 
BMD from pre testing (0.846±0.02 g/cm2) to post testing (0.862±0.02 g/cm2).  Control subjects 
were unable to significantly (P>0.05) increase pelvis BMD from pre testing (0.823±0.03 g/cm2) 
to post testing (0.838±0.02 g/cm2). 
 
 
 
 
 
 
Figure 13 displays the change in spine bone mineral density (g/cm
2
) for all lean 
groups, from pre to post testing. N= 11, LT; 8, LC 
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Figure 14 
 
 
Bone Mineral Content 
Bone mineral content expressed in grams are displayed in table 3. 
Table 3a: Bone Mineral Content (Obese) 
DEXA 
Scan 
Obese Treatment Percent 
Change 
Obese  Control Percent 
Change 
TB 
(Pre|Post) 
 
1758±73.4 
 
1864±76.6* 
 
+5.69% 
 
1726±142.9 
 
1794±139.4* 
 
+3.79% 
Arms 
(Pre|Post) 
 
185.7±8.73 
 
198.8±9.39* 
 
+6.59% 
 
175.4±15.7 
 
190.8±18.0* 
 
+8.07% 
Legs 
(Pre|Post) 
 
720.9±35.1 
 
777.1±36.7* 
 
+6.46% 
 
685.8±64.4 
 
738.6±68.7* 
 
+7.16% 
Pelvis 
(Pre|Post) 
 
202.2±17.5 
 
221.9±14.4* 
 
+8.88% 
 
189.0±21.9 
 
191.0±21.1 
 
+1.04% 
Spine 
(Pre|Post) 
 
172.9±10.6 
 
173.7±9.0 
 
+0.46% 
 
153.8±13.8 
 
160.6±14.2 
 
+0.04 
       
Note:  Bone mineral content in grams (g) scan pre test and post test; * P<0.05 pre vs pos; Reported as the mean ± 
SEE 
Figure 14 displays the change in spine bone mineral density (g/cm
2
) for all obese 
groups, from pre to post testing. N= 29, OT; 12, OC 
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Table 3b: Bone Mineral Content (Lean) 
DEXA 
Scan 
Lean Treatment Percent 
Change 
Lean Control Percent 
Change 
TB 
(Pre|Post) 
 
1332±78.7 
 
1443±87.7* 
 
+7.69% 
 
1376±133.2 
 
1449±137.8* 
 
+5.04% 
Arms 
(Pre|Post) 
 
139.8±14.3 
 
152.7±16.1* 
 
+8.45% 
 
152.1±23.9 
 
168.7±24.9* 
 
+9.84% 
Legs 
(Pre|Post) 
 
505.0±43.3 
 
549.5±49.3* 
 
+8.10% 
 
541.1±70.0 
 
567.4±70.6* 
 
+4.64% 
Pelvis 
(Pre|Post) 
 
141.1±11.9 
 
146.5±11.9* 
 
+3.69% 
 
155.2±16.5 
 
156.5±18.9 
 
+0.83% 
Spine 
(Pre|Post) 
 
101.9±8.97 
 
109.6±5.05 
 
+7.03% 
 
105.7±9.98 
 
119.4±10.1 
 
+11.5% 
       
Note:  Bone mineral content in grams (g)scan pre test and post test; *P<0.05 pre vs post; Reported as the mean ± 
SEE 
 
Total Body Bone Mineral Content 
The change in total body bone mineral content (grams) for all obese groups, from pre to 
post testing, is displayed (Figure 15).  Treatment subjects significantly (P<0.001) increased total 
body BMC from pre testing (1758±73.4g) to post testing (1864±76.5g).  Control subjects 
significantly (P<0.05) increased total body BMC from pre testing (1726±142.9g) to post testing 
(1794±139.4 g/cm2). 
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Figure 15 
 
 
The change in total body bone mineral content (grams) for all lean groups, from pre to post 
testing, is displayed (Figure 16).  Treatment subjects significantly (P<0.001) increased total body 
BMC from pre testing (1332±78.6g) to post testing (1443±87.7g).  Control subjects significantly 
(P<0.001) increased total body BMC from pre testing (1376±133.2g) to post testing 
(1449±137.8 g/cm2). 
 
 
 
 
 
 
Figure 15 displays the change in total body bone mineral content (grams) for all obese 
groups, from pre to post testing. N= 29, OT; 12, OC 
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Figure 16 
 
 
Arm Bone Mineral Content 
The change in arm bone mineral content (grams) for all obese groups, from pre to post 
testing, is displayed  (Figure 17).  Treatment subjects significantly (P<0.001) increased arm BMC 
from pre testing (185.7±8.73g) to post testing (198.8±9.39g).  Control subjects significantly 
(P<0.007) increased arm BMC from pre testing (175.4±15.7g) to post testing (190.8±18.0g). 
 
 
 
 
 
Figure 16 displays the change in total body bone mineral content (grams) for all lean 
groups, from pre to post testing. N= 11, LT; 8, LC 
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Figure 17 
 
 
The change in arm bone mineral content (grams) for all lean groups, from pre to post testing, is 
displayed (Figure 18).  Treatment subjects significantly (P<0.05) increased arm BMC from pre 
testing (139.8±14.3g) to post testing (152.7±16.1g).  Control subjects significantly (P<0.05) 
increased arm BMC from pre testing (152.1±23.9g) to post testing (168.7±24.9g). 
 
 
 
 
 
 
 
Figure 17 displays the change in arm bone mineral content (grams) for all lean groups, 
from pre to post testing.  N= 29, OT; 12, OC 
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Figure 18 
 
 
Leg Bone Mineral Content 
The change in leg bone mineral content (grams) for all obese groups, from pre to post 
testing, is displayed (Figure 19).  Treatment subjects significantly (P<0.001) increased leg BMC 
from pre testing (720.9±35.1g) to post testing (777.1±36.7g).  Control subjects significantly 
(P<0.01) increased leg BMC from pre testing (685.8±64.4g) to post testing (738.6±68.7g). 
 
 
 
 
 
Figure 18 displays the change in arm bone mineral content (grams) for all lean groups, 
from pre to post testing. N= 11, LT; 8, LC 
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Figure 19 
 
 
The change in leg bone mineral content (grams) for all lean groups, from pre to post testing is 
displayed (Figure 20).  Treatment subjects significantly (P<0.001) increased leg BMC from pre 
testing (505.0±43.3g) to post testing (549.5.7±49.3.1g).  Control subjects significantly (P<0.01) 
increased leg BMC from pre testing (541.1.1±70.0g) to post testing (567.4±70.6g). 
 
 
 
 
 
 
 
Figure 19 displays the change in leg bone mineral content (grams) for all obese groups, 
from pre to post testing. N= 29, OT; 12, OC 
44 
 
 
 
 
Figure 20 
 
 
Pelvis Bone Mineral Content 
The change in pelvis bone mineral content (grams) for all obese groups, from pre to post 
testing is displayed (Figure 21).  Treatment subjects significantly (P<0.05) increased pelvis BMC 
from pre testing (202.2±17.5g) to post testing (221.9±14.4g).  Control subjects significantly 
(P<0.01) increased pelvis BMC from pre testing (189.0±21.9g) to post testing (191.0±21.1g). 
 
 
 
 
 
Figure 20 displays the change in leg bone mineral content (grams) for all lean groups, 
from pre to post testing. N= 11, LT; 8, LC 
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Figure 21 
 
 
The change in pelvis bone mineral content (grams) for all lean groups, from pre to post testing, 
is displayed (Figure 22).  Treatment subjects were able to significantly (P<0.05) increase pelvis 
BMC from pre testing (134.0±10.0g) to post testing (146.5±11.8g).  Control subjects increased 
pelvis BMC from pre testing (155.2±16.5g) to post testing (156.5±18.9g). 
 
 
 
 
 
 
 
Figure 21 displays the change in pelvis bone mineral content (grams) for all obese 
groups, from pre to post testing. N= 29, OT; 12, OC 
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Figure 22 
 
 
Spine Bone Mineral Content 
The change in spine bone mineral content (grams) for all obese groups, from pre to post 
testing is displayed (Figure 23).  Treatment subjects significantly (P>0.05) increased spine BMC 
from pre testing (172.8±10.6g) to post testing (173.7±8.98g).  Control subjects significantly 
(P>0.05) increased spine BMC from pre testing (153.8±13.8g) to post testing (160.6±14.2g). 
 
 
 
 
 
Figure 22 displays the change in pelvis bone mineral content (grams) for all lean groups, 
from pre to post testing. N= 11, LT; 8, LC 
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Figure 23 
 
 
The change in spine bone mineral content (grams) for all lean groups, from pre to post testing, 
is displayed (Figure 24).  Treatment subjects increased spine BMC from pre testing 
(172.8±10.6g) to post testing (173.7±8.98g).  Control subjects significantly (P>0.05) increased 
spine BMC from pre testing (153.8±13.8g) to post testing (160.6±14.2g). 
 
 
 
 
 
 
 
Figure 23 displays the change in spine bone mineral content (grams) for all obese 
groups, from pre to post testing. N= 29, OT; 12, OC 
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Figure 24 
 
 
Aim 2: Activity Monitoring 
Three day step count was measured at weeks 0, 4, 8, 12, and 16 using a ymax accelerometer.  
Average 3-day step counts are displayed in Table 4. 
Table 4: Average 3-day Step Count  
 Week 0 
Steps 
Week 4 Steps Week 8 Steps Week 12 Steps Week 16 
Steps 
Obese 
Treatment 
6902.76±403.
1 
7228.65±610.6 8697.34±594.3 8574.63±558.7 7183.72±580.9 
Obese 
Control 
8164.40±814.
2 
7142.33±950.7 10710.25±3406.8 8526.57±1223.8 6499.44±510.0 
Lean 
Treatment 
8609.33±640.
1 
10118.11±1613.9 10684.88±1254.9 7506.75±618.4 8017.50±682.9 
Lean 
Control 
7533.58±979.
6 
7185.49±741.6 9703.79±1027.0 8550.60±1171.7 6841.58±603.3 
 Average 3-day step counts are displayed in Table 4. Reported as the mean ± SEE;  
Figure 24 displays the change in spine bone mineral content (grams) for all lean groups, 
from pre to post testing. N= 11, LT; 8, LC 
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The average number of steps was computed by averaging the total step counts for a three day period.  
These days included an exercise program day, non-program day, and a weekend day.  For non-exercisers 
these days included two week days, and a weekend day.(Figure 25).   
Figure 25 
 
 
 
Aim 3: Nutritional Monitoring  
Three day food records were kept by participants at weeks 0, 4, 8, 12, and 16.  These 
records were then entered into Nutritionist Pro, a computer software program, to be analyzed 
for some substrates known to effect the growth of bone.  Table 5a.-5c. reflects the data 
obtained from 3 day food records.   Figures 26, 27, and 28 graphically display these data along 
with the recommended dietary allowance (RDA) for each respective nutrient.  
Table 5a. Dietary Calcium Intake in Obese and Lean prepubescent children undergoing either 
a 16-week physical activity treatment or a control period of 16 weeks without treatment.  
 
Figure 25 displays the average number of steps taken in a three day period at weeks 0, 
4, 8, 12, and 16.  N= 29, OT; 12, OC; 11, LT; 8, LC 
 
50 
 
 
Calcium Week 0 Week 4 Week 8  Week 12 Week 16 
Obese 
Treatment 
763.8±57.3 737.6±59.6 677.8±55.1 742.3±79.4 671.9±38.6 
Obese Control 541.6±100.5 419.3±106.4 483.1±107.2 617.9±87.5 762.9±130.7 
Lean Treatment 639.1±81.6 795.6±76.5 587.9±55.2 529.0±60.7 758.8±108.4 
Lean Control 541.6±61.5 419.3±81.2 483.1±70.1 617.9±126.7 762.9±163.1 
RDA 1,300 1,300 1,300 1,300 1,300 
 
   
Figure 26 
 
Table 5b.  Dietary Phosphorus Intake in Obese and Lean prepubescent children undergoing 
either a 16-week physical activity treatment or a control period of 16 weeks without 
treatment. 
Phosphorus  Week 0 Week 4 Week 8  Week 12 Week 16 
Obese Treatment 889.5±56.0 866.7±39.6 782.9±73.7 865.1±81.1 815.8±57.8 
Obese Control 913.4±117.0 797.3±112.9 952.4±187.6 855.4±114.9 1040.3±100.1 
Lean Treatment 684.5±40.4 857.5±89.5 704.7±78.4 745.4±94.9 915.0±152.1 
Note:  Calcium is recorded as a three day average in milligrams (mg) ; Reported as the mean ± SEE 
Figure 26 displays the average dietary intake of calcium over a three day period for all 
groups.  N= 29, OT; 12, OC; 11, LT; 8, LC 
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Lean Control 1283.8±262.6 598.6±90.2 663.1±78.7 801.2±155.8 1175.5±187.7 
RDA 1,250 1,250 1,250 1,250 1,250 
 
 
 
 
 
 
Figure 27 
 
Table 5c.  Dietary Vitamin D Intake in Obese and Lean prepubescent children undergoing 
either a 16-week physical activity treatment or a control period of 16 weeks without 
treatment.   
Note: Phosphorus is recorded as a three day average in milligrams(mg); Reported as the mean ± SEE 
Figure 27 displays the average dietary intake of phosphorous over a three day period for 
all groups.  N= 29, OT; 12, OC; 11, LT; 8, LC 
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Dietary Vitamin D Week 0 Week 4 Week 8  Week 12 Week 16 
Obese Treatment 2.7±0.3 2.9±0.4 2. 5±0.4 3.6±0.6 2.9±0.4 
Obese Control 2.7±1.0 3.3±1.0 3.6±1.2 4.2±1.0 4.9±1.3 
Lean Treatment 2.2±0.5 3.6±0.6 3.2±0.4 2.0±0.3 3.7±0.8 
Lean Control 4.9±1.3 2.5±0.5 3.6±0.7 3.9±1.0 5.6±1.5 
RDA 5 5 5 5 5 
 
Figure 28 
 
 
Table 6 displays the total body BMC to weight, total body BMC to lean tissue, and total body 
BMC to fat tissue ratios as mean plus or minus the standard deviation.  The Obese treatment 
group increase total body BMC/weight ratio significantly (p<0.05) pre (0.031±0.003 BMC/kg) to 
post testing (0.032±0.004 BMC/kg).  There was also a significant increase in total body BMC/fat 
tissue ratio from pre testing (0.057±0.010 BMC/kg) to post testing (0.058±0.010 BMC/kg) in the 
obese treatment group. 
Note: Dietary Vitamin D is recorded as a three day average in micrograms(µg) ; Reported as the mean ± SEE 
 
Figure 28 displays the average dietary intake of phosphorous over a three day 
period for all groups.  N= 29, OT; 12, OC; 11, LT; 8, LC 
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Table 6. TB BMC/Weight   
 Pre Post P value 
Lean 
Treatment 
0.038±0.004 BMC/kg 0.039±0.004 BMC/kg p=0.12 
Obese 
Treatment 
0.031±0.003 BMC/kg 0.032±0.004 BMC/kg p=0.03* 
 Pre Post  
Lean Control 0.039±0.004 BMC/kg 0.039±0.004 BMC/kg p=0.40 
Obese 
Control 
0.041±0.015 BMC/kg 0.040±0.012 BMC/kg p=0.22 
    
  
TB BMC/Lean Tissue 
 
 Pre Post p value 
Lean 
Treatment 
0.051±0.005 BMC/kg 0.052±0.004 BMC/kg p=0.33 
Obese 
Treatment 
0.057±0.010 BMC/kg 0.058±0.010 BMC/kg p=0.70 
    
Lean Control 0.050±0.003 BMC/kg 0.051±0.003 BMC/kg p=0.85 
Obese 
Control 
0.055±0.009 BMC/kg 0.055±0.008 BMC/kg p=0.70 
    
 TB BMC/Fat Tissue  
 Pre Post p value 
Lean 
Treatment 
0.051±0.005 BMC/kg 0.052±0.004 BMC/kg p=0.74 
Obese 
Treatment 
0.057±0.010 BMC/kg 0.058±0.010 BMC/kg p=0.01* 
    
Lean Control 0.024±0.068 BMC/kg 0.024±0.101 BMC/kg p=0.97 
Obese 
Control 
0.090±0.014 BMC/kg 0.087±0.014 BMC/kg p=0.15 
 
 
 
 
 Figure 31 displays the average dietary intake of phosphorous over a three day 
period for all groups.  N= 29, OT; 12, OC; 11, LT; 8, LC 
     
*Indicates significant difference from pre to post testing. 
 
 
 
  
Chapter 5 Discussion  
The current obesity epidemic has become a major health crisis to citizens around the 
United States.  The increase in vast amounts of cheap calorie enriched foods is wreaking havoc 
on a very unstable healthcare system through the added cost of health related sickness brought 
about by obesity.  Obesity has been successfully linked to a plethora of different disease states 
including cardiovascular disease, diabetes, and stroke.  Although many people might not 
recognize the trends, the obesity epidemic is also putting children as young as 5 and 6 years of 
age at a health disadvantage compared to children of a healthier weight (Andersen 2006).    
Physical activity can be one way to combat obesity.  Increases in caloric expenditure through 
physical activity, can create a situation where fat stores are reduced.   Promotion of physical 
activity programs in children can decrease cholesterol levels, insulin levels and increase lean 
tissue, HDL cholesterol and bone density (Raitakan 1994; MacKelvie 2004).  With regard to bone 
health in particular, there is a good amount of information supporting the acquisition of bone 
mineral density (BMD) through exercise, in both adults and children.  However, no studies to 
date have investigated how a sixteen week physical exercise program can influence bone 
acquisition in lean and obese children.    Previous studies have shown that overweight and 
obese children are at an increased risk of bone fracture due to low bone mass and bone area for 
weight (Goulding 2000; Goulding 2001), but this information does not suggest whether exercise 
could increase bone mass in these obese children.  
Data obtained through the current study shows total body BMD, pre testing to post 
testing, increased in both lean and obese groups regardless of treatment.  There is a slightly 
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larger response of bone density in experimental groups when compared to control groups.    
Over a sixteen week period the obese experimental group increased total body bone mineral 
density by 2.6%.  The lean group expressed an increase in total body BMD of 2.6%.  Previous 
longitudinal exercise studies have shown increases in BMD in children, but these studies are 
unlike the current study in that the current study gave emphasis on reaching and maintaining a 
heart rate above 140 beats per minute or 65 percent of maximal heart rate.  It is apparent from 
total body BMD results obtained in this study that prepubescent children 9-11 years of age can 
experience a small percentage increase in total BMD by simply exercising for three hours a 
week, for sixteen weeks.   
Exercise has been shown to be very site specific when it comes to new bone formation 
(Bradney 1998; Bass 1998).  For this reason, along with total body measurements, the current 
study also reports descriptive data on how bone density of the legs, arms, pelvis and spine, 
changed from pretest to post testing in both treatment and control groups.  Of the different 
sites analyzed there was a significant increase of at the spine of the obese treatment group, 
while no such significance is found for the obese control group.   A previously reported study 
reports no differences in obese childhood spinal bone mineral density compared to control 
subjects (Schepper, 1995).  
When analyzing the data from lean children there are several different regions that 
increase in bone density for the treatment group, but not in the control group.  Total-body, legs 
and spinal density all increase in the lean treatment group, but not in the control groups.  These 
findings agree with similar findings in prepubertal gymnasts that significantly increase spine, 
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leg, and total body BMD over time, compared to control groups (Bass  1998).   The most 
substantial increase occurs in the spine, where the treatment group experienced an increased 
BMD of 2.56% versus a control group that only increased 0.94%.   
Classifying participants by BMD exclusively can fail to account for the change in bone 
thickness (Katzman 1991).    To get a better understanding of bone thickness, it is important to 
consider the BMC measure by extracting the area component from the density formula.  With 
regards to BMC, it is worth mentioning first that the participants with a higher BMI percentile 
(>95th) started at baseline with higher BMC values than the lower BMI percentile (<85th) 
(p<0.05).  This is believed to be correlated to the greater amount of weight bearing these 
children perform in everyday activities due to their larger mass.  When classified by the change 
in bone mineral content, pre testing to post testing, the change in BMC was found to be higher 
at all sites in both lean and obese treatment groups compared to controls.  In the obese 
category, children increase total body BMC in the treatment group by 106 grams, or 5.69% 
(p<0.05).  In the obese control group there was only a total body increase of BMC by 68 grams 
or 3.79%.  Interestingly, lean treatment participants were able to increase total body BMC by 
111 grams, or 7.69% (p<0.05), while lean control participants increased total body BMC by 73 
grams, or 5.04%.  It is likely that the higher amounts of BMC, expressed by the lean and obese 
treatment groups, could have a positive effect on bone fracture prevention.  Previous evidence 
shows that the stress placed on the bone during exercise allows for more calcium deposits to 
build up, these deposits can increase the strength of the lattice structure specific to bone tissue.  
If this lattice structure is indeed strengthened, the treatment children could have greater 
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protection from fall related fractures.  Cortical bone is the most abundantly found skeletal tissue 
throughout the body, comprising eighty percent of the skeletal tissue. It is therefore likely that a 
good majority of the bone that is acquired through exercise is indeed cortical bone.  Cortical 
bone is found on the outside layers of bone tissue and can be protective against bone fractures 
due to its strength, and has also been found to increase in size at specific sites through sporting 
events such as tennis (Krahl 1994).   
It is evident from the results that BMC is changed very rapidly over a sixteen week 
period in prepubertal children regardless of group.  Obese treatment children increased their 
BMC values 6.63 grams per week, while the obese control group was only increasing BMC by 
4.25 grams per week.  The treatment group had over a 2 gram net gain per week, that amount 
can create a substantial effect on bone enhancement annually.  If current conditions were held 
constant for both groups and BMC continued to accrue at this rate over a year’s period, 
treatment participants would continue to increase their total body BMC by 344.5 grams, which 
would be the equivalent to almost 1/5th of their pretest bone mineral content.   The obese 
control children’s total body BMC, if current conditions were held constant, would increase 
annually by 221 grams, or 1/8th of pretest values.  Lean children increased total body BMC as 
well, and if current conditions were held constant for a year’s period and the lean treatment 
group continued to gain 6.94 grams per week they would be able to increase total body BMC by 
360.8 grams annually.  360.8 grams comes to be over 1/4th of pretest BMC value or an increase 
of BMC one standard deviation from pretest values.  Lean control subjects gaining 4.56 grams 
per week would only be able to increase total body BMC values by 237.3 grams annually, or 
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almost 1/6th of pretest values. A review of controlled trials on prepubertal children and bone 
formation through exercise, show an increase in total body bone mineral values of 1.1-4.5% 
(Hind, 2007).  Our current study corresponds with these percentage increases for exercisers, 
but what is most significant about these trials, compared to ours, is the program time.  The 
exercise intervention used with our study was only 4 months long (16 weeks), while the studies 
mentioned in the review were implemented for at least 7 months or longer.  The approach used 
with this studies exercise protocol was different compared to previous investigations.  A target 
heart rate of >140 beats per exercise session was used with all training participants as opposed 
to a set routine as explored in the other studies.  The results and the subsequent gains in BMD 
and BMC in the lean and obese treatment participants gives solid evidence that games such as 
the ones played in this study that induce an exercise heart rate >140 beats per minute can 
indeed increase bone mineral accrue.    Due to the limited amount of data concerning the 
growth patterns of bone during prepubertal childhood, it is very hard to predict if the current 
rate of growth experienced with our participants would indeed continue or if some physiological 
element would further enhance, or limit biological processes of bone growth.  Judging from this 
data these children, who have yet to experience major levels of steroid hormone interaction as 
seen in puberty, have increased bone mineral accrual over sixteen weeks, which could add to an 
even greater net gain of BMD and BMC when with children actually hit puberty. It appears that 
experimental group in this population is at a slight physiological advantage of BMC accrual 
versus the control groups.   
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Other studies have indicated that obese children are at more risk to fracture due to a 
higher load placement on the skeleton from extra weight (Goulding 2000, Goulding 2001).  With 
our study these findings are confirmed in Table 6.  Results show that obese children have a poor 
BMC to body weight ratio compared to lean children, suggesting that the obese children’s bones 
are in fact weaker, relative to weight.  A promising finding within the obese population is that 
the obese children improved their BMC to weight ratio by performing the exercise protocol 
prescribed in this study (p<0.05).  Improving the ratio of BMC to weight can provide the obese 
children greater protection from fracture, as well as other bone abnormalities.  Obese children 
also had a higher total body BMC/fat tissue ratio than lean children at baseline (p<0.001), 
indicating that this population has a greater amount of fat per gram of bone than the lean 
children.  Through exercise intervention obese children increased its BMC/fat tissue ratio as 
well.      
One of the most important factors influencing a child’s ability to increase bone stores is 
diet.  Johnston et al. showed that prepubertal twins receiving supplements of calcium to reach 
recommended dietary allowances can indeed significantly increase BMD values compared to 
controls subjects (Johnston 1992; Ruiz 1995).  Likewise, studies have shown that children 
ingesting more than 1000 mg of calcium daily have a higher BMC than children consuming less 
(Chan 1991).   With the current study, dietary calcium was obtained through a 3 day dietary 
recall in order to understand if recommended dietary allowances were being reached.  Children 
in this study were not receiving intakes near the recommended 1300 mg/day.  . If these calcium 
poor diets continue longitudinally these children could be at risk of calcium deficiency fractures 
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or diseases such as osteoporosis.   Bakary et al. investigate populations of children severely 
deprived of calcium (<342mg/d) and found these children were subject to poor growth, and 
BMC values.  After supplementation of calcium (1000mg/d) for a 12 month timeframe, children 
significantly increased BMC values (Bakary 2000).   
 The children in this study were found to ingest more phosphorus over the 16 week 
intervention than calcium.  Bone building processes relay heavily on the maintenance of a 
certain calcium/phosphorus ratio.   If phosphorus levels rise in the blood, calcium resorption will 
occur in the bone and gut to maintain proper ratio levels in the blood, thus minimal bone can 
be created and stored.  Bone stores are increasing with the treatment groups despite the higher 
levels of dietary phosphorus compared to calcium. The increases in phosphorus through the diet 
can be correlated to the rise in soft drink intake among younger populations (HARNACK 1999; 
Nielsen 2004).  The increase in soft drink consumption has been linked to a decrease in milk 
consumption, thus less calcium rich products such as milk are being used by younger 
populations.        
Vitamin D aids absorption of calcium from the intestinal track.  Though vitamin D is 
found to be very low among the groups in the current study, this measure can be an inaccurate 
indicator of true vitamin D status, because this hormone can be gained from contact with 
sunlight.  15 minutes of sunlight can provide the body with more than enough vitamin D needed 
for proper bodily function (Gartner 2003).  
Our study does present some limitations.  Biomarkers of bone turnover such as 
parathyroid hormone, and growth hormone were not measured in the participants.  Without 
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this data no determination can be made as to what impact these hormones have on the 
growing body of prepubescent children.  Blood values would also be valuable to obtain to make 
inferences concerning the dietary information.  Levels of serum calcium, vitamin D, and 
phosphorus could allow us to make better comparisons between diet and bone metabolism.   
 
 
 
  
Chapter 6: Conclusion 
In conclusion the results of the current study show that children, ages 8-11, can increase 
bone mineral density, regardless of exercise load.  In both instances (lean and obese) the 
treatment group had a slightly greater increase in both BMD and BMC accrue versus the control 
groups.  The findings in this study are in agreement with findings of other studies that 
investigated BMD and BMC, in prepubescent children.  This study shows that lean children have 
a higher BMC/weight ratio, and BMC/fat ratio at pre and post testing compared to obese 
children.  Obese children carry more weight than lean children, so this population could be at 
more risk of bone fracture due to these poor ratios.  Promisingly, the treatment protocol 
increased the BMC/fat ratio, and BMC/weight ratio in the obese children, from pretesting to 
post testing (Table 6).  As mentioned previously, it is important to draw distinctions in this study 
compared to others that have studied prepubescent children so that proper exercise protocols 
can be established to efficiently increase both BMC and BMD in the target population.  The 
exercise protocol used with the current study only required that the children keep a target heart 
rate of >140 beats per minute.  This allowed the child to pick a variety of different activities 
during their exercise sessions, which promoted adherence for the program because the child 
would pick games that he/she felt comfortable performing.   Increases in skeletal mass are 
shown to be very vital in the battle against osteoporosis, osteopenia, as well as reduced fracture 
risk; therefore, it is important to know that exercise can indeed help increase both BMD and 
BMC during prepubertal childhood.  Further longitudinal research could be useful to understand 
if the changes in BMD and BMC continue.   
  
 
References  
  
A. Goulding, R. W. Taylor, I. E. Jones, P. J. Manning and S. M. Williams. (2000). Spinal overload: 
A concern for obese children and adolescents? Osteoporosis International, 13(10), 835-
840.  
Andersen, L. B., Harro, M., Sardinha, L. B., Froberg, K., Ekelund, U., Brage, S., & Anderssen, S. A. 
(2006). Physical activity and clustered cardiovascular risk in children: A cross-sectional 
study (the european youth heart study). The Lancet, 368(9532), 299-304. doi:DOI: 
10.1016/S0140-6736(06)69075-2  
Bailey, D. A., Mckay, H. A., Mirwald, R. L., Crocker, P. R. E., & Faulkner, R. A. (1999). A six-year 
longitudinal study of the relationship of physical activity to bone mineral accrual in growing 
children: The university of saskatchewan bone mineral accrual study. Journal of Bone and 
Mineral Research, 14(10), 1672-1679. doi:10.1359/jbmr.1999.14.10.1672  
Bass, S. (2000). The prepubertal years: A uniquely opportune stage of growth when the 
skeleton is most responsive to exercise. Sports Medicine, 30, 73-78.  
Bass, S., Pearce, G., Bradney, M., Hendrich, E., Delmas, P. D., Harding, A., & Seeman, E. (1998). 
Exercise before puberty may confer residual benefits in bone density in adulthood: Studies 
in active prepubertal and retired female gymnasts. Journal of Bone and Mineral Research, 
13(3), 500-507. doi:10.1359/jbmr.1998.13.3.500  
  
 
Behre, H. M., Kliesch, S., Leifke, E., Link, T. M., & Nieschlag, E. (1997). Long-term effect of 
testosterone therapy on bone mineral density in hypogonadal men. Journal of Clinical 
Endocrinology Metabolism, 82(8), 2386-2390. doi:10.1210/jc.82.8.2386  
Boot, A. M., de Ridder, M. A. J., Pols, H. A. P., Krenning, E. P., & de Muinck Keizer-Schrama, S. M. 
P. F. (1997). Bone mineral density in children and adolescents: Relation to puberty, calcium 
intake, and physical activity. Journal of Clinical Endocrinology Metabolism, 82(1), 57-62. 
doi:10.1210/jc.82.1.57  
Bradney, M., Pearce, G., Naughton, G., Sullivan, C., Bass, S., Beck, T., . . . Seeman, E. (1998). 
Moderate exercise during growth in prepubertal boys: Changes in bone mass, size, 
volumetric density, and bone strength: A controlled prospective study. Journal of Bone and 
Mineral Research, 13(12), 1814-1821. doi:10.1359/jbmr.1998.13.12.1814  
Briefel, R. R., Johnson, C. L. (2004). Secular trends in dietary intakes in the united states. Annual 
Review of Nutrition, 1(24), 401-403. doi:2004  
Chan, G. M. (1991). Dietary calcium and bone mineral status of children and adolescents. 
Archives of Pediatrics Adolescent Medicine, 145(6), 631-634. 
doi:10.1001/archpedi.1991.02160060049019  
Crawford, P. B., Obarzanek, E., Morrison, J., & Sabry, Z. I. (1994). Comparative advantage of 3-
day food records over 24-hour recall and 5-day food frequency validated by observation of 
  
 
9- and 10-year-old girls. Journal of the American Dietetic Association, 94(6), 626-630. 
doi:DOI: 10.1016/0002-8223(94)90158-9  
Crawford, P. B., Obarzanek, E., Morrison, J., & Sabry, Z. I. (1994). Comparative advantage of 3-
day food records over 24-hour recall and 5-day food frequency validated by observation of 
9- and 10-year-old girls. Journal of the American Dietetic Association, 94(6), 626-630. 
doi:DOI: 10.1016/0002-8223(94)90158-9  
Dibba, B., Prentice, A., Ceesay, M., Stirling, D. M., Cole, T. J., & Poskitt, E. M. (2000). Effect of 
calcium supplementation on bone mineral accretion in gambian children accustomed to a 
low-calcium diet1. The American Journal of Clinical Nutrition, 71(2), 544-549.  
Domel, S., Baranowski, T., Leonard, S., Davis, H., Riley, P., & Baranowski, J. (1994). Accuracy of 
fourth- and fifth-grade students' food records compared with school-lunch observations. 
The American Journal of Clinical Nutrition, 59(1), 218S-220S.  
Enns, C. W. (2002). Trends in food and nutrient intakes by children in the united states. Family 
Economics and Nutrition Review, 14(2), 56-68. doi:2002  
Faulkner, R. A., Houston, C. S., Bailey, D. A., Drinkwater, D. T., McKay, H. A., & Wilkinson, A. A. 
(1993). Comparison of bone mineral content and bone mineral density between dominant 
and nondominant limbs in children 8?16 years of age. American Journal of Human Biology, 
5(4), 491-499. doi:10.1002/ajhb.1310050413  
  
 
French, S. A., Lin, B., & Guthrie, J. F. (2003). National trends in soft drink consumption among 
children and adolescents age 6 to 17 years: Prevalence, amounts, and sources, 1977/1978 
to 1994/1998. Journal of the American Dietetic Association, 103(10), 1326-1331. doi:DOI: 
10.1016/S0002-8223(03)01076-9  
Gartner, L. M., Greer, F. R., Section on Breastfeeding, , & Committee on Nutrition, . (2003). 
Prevention of rickets and vitamin D deficiency: New guidelines for vitamin D intake. 
Pediatrics, 111(4), 908-910.  
Goulding, A., Taylor, R. W., Jones, I. E., McAuley, K. A., Manning, P. J., & Williams, S. M. (2000). 
Overweight and obese children have low bone mass and area for their weight. 
International Journal of Obesity, 24(5), 627-632. doi:10.1038/sj.ijo.0801207  
Groff, J. L., & Gropper, S. S. (1999). Advanced nutrition and human metabolism. Belmont: 
Wadsworth Publishing Company, Inc.  
HARNACK, L., STANG, J., & STORY, M. (1999). Soft drink consumption among US children and 
adolescents: Nutritional consequences. Journal of the American Dietetic Association, 99(4), 
436-441. doi:DOI: 10.1016/S0002-8223(99)00106-6  
Hind, K., & Burrows, M. (2007). Weight-bearing exercise and bone mineral accrual in children 
and adolescents: A review of controlled trials. Bone, 40(1), 14-27. doi:DOI: 
10.1016/j.bone.2006.07.006  
  
 
Iranmanesh A, Lizarralde G, Veldhuis JD. (1991). Age and relative adiposity are specific negative 
determinants of the frequency and amplitude of growth hormone (GH) secretory bursts 
and the half-life of endogenous GH in healthy men. J Clin Endocrinol Metab, 1, 1081-1088.  
Johnston, C. C., Miller, J. Z., Slemenda, C. W., Reister, T. K., Hui, S., Christian, J. C., & Peacock, M. 
(1992). Calcium supplementation and increases in bone mineral density in children. New 
England Journal of Medicine, 327(2), 82-87.  
Jones, G., & Dwyer, T. (1998). Bone mass in prepubertal children: Gender differences and the 
role of physical activity and sunlight exposure. Journal of Clinical Endocrinology 
Metabolism, 83(12), 4274-4279. doi:10.1210/jc.83.12.4274  
K. Thorsen. (1997). Effects of moderate endurance exercise on calcium, parathyroid hormone, 
and markers of bone metabolism in young women. Calcified Tissue International, 1(60), 16-
20. doi:1997  
Kanaley JA, Weltman JY, Veldhuis JD, et al. (1997). Human growth hormone response to 
repeated bouts of aerobic exercise. J Appl Physiol, 83, 1756-1761.  
Kanis, J. A., Melton, L. J., Christiansen, C., Johnston, C. C., & Khaltaev, N. (1994). The diagnosis of 
osteoporosis. Journal of Bone and Mineral Research, 9(8), 1137-1141. 
doi:10.1002/jbmr.5650090802  
  
 
KATZMAN, D. K., BACHRACH, L. K., CARTER, D. R., & MARCUS, R. (1991). Clinical and 
anthropometric correlates of bone mineral acquisition in healthy adolescent girls. Journal 
of Clinical Endocrinology Metabolism, 73(6), 1332-1339. doi:10.1210/jcem-73-6-1332  
KH Fleming, J. H. ((1994),). Consumption of calcium in the U.S.: Food sources and intake levels. J 
Nutr, 1(124), 1426S--1430S.  
Khosla S, Melton LJ, Dekutoski MB, Achenbach SJ, Oberg AL, Riggs BL. (2003). Incidence of 
childhood distal forearm fractures over 30 years. A 
population-based study. JAMA, 290, 1479-1485.  
Krahl, H., Michaelis, U., Pieper, H., Quack, G., & Montag, M. (December 1994). Stimulation of 
bone growth through sports. The American Journal of Sports Medicine, 22(6), 751-757. 
doi:10.1177/036354659402200605  
L. H. Foo, Q. Zhang, K. Zhu, G. Ma, A. Trube, H. Greenfield, & and D. R. Fraser. (2008). 
Relationship between vitamin D status, body composition and physical exercise of  
adolescent girls in beijing. Osteoporosis International, 20(10), 417-425.  
Lau, E., Donnan, S., Barker, D. J., & Cooper, C. (1988). Physical activity and calcium intake in 
fracture of the proximal femur in hong kong. British Medical Journal, 297(6661), 1441-
1443. doi:10.1136/bmj.297.6661.1441  
  
 
Leonard, M. B., Shults, J., Wilson, B. A., Tershakovec, A. M., & Zemel, B. S. (2004). Obesity 
during childhood and adolescence augments bone mass and bone dimensions. The 
American Journal of Clinical Nutrition, 80(2), 514-523.  
Linkhart, T. A., Mohan, S., & and Baylink, D. J. (1996). Growth factors for bone growth and 
repair: IGF, TGF beta and BMP. Bone, 1, 971-977.  
Livingstone, M. B. E., & Robson, P. J. (2000). Measurement of dietary intake in children. 
Proceedings of the Nutrition Society, 59(02), 279. doi:10.1017/S0029665100000318  
MacKelvie, K. J., Khan, K. M., & McKay, H. A. (2002). Is there a critical period for bone response 
to weight-bearing exercise in children and adolescents? a systematic review. British Journal 
of Sports Medicine, 36(4), 250-257. doi:10.1136/bjsm.36.4.250  
MacKelvie, K. J., Petit, M. A., Khan, K. M., Beck, T. J., & McKay, H. A. (2004). Bone mass and 
structure are enhanced following a 2-year randomized controlled trial of exercise in 
prepubertal boys. Bone, 34(4), 755-764. doi:DOI: 10.1016/j.bone.2003.12.017  
Manzoni, P., Brambilla, P., Pietrobelli, A., Beccaria, L., Bianchessi, A., Mora, S., & Chiumello, G. 
(1996). Influence of body composition on bone mineral content in children and 
adolescents. The American Journal of Clinical Nutrition, 64(4), 603-607.  
Marshall WA, & Tanner JM. (1969). Variations in pattern of pubertal changes in girls. Arch Dis 
Child, 44, 291-303.  
  
 
Marshall WA, & Tanner JM. (1970). Variations in the pattern of pubertal changes in boys. Arch 
Dis Child 45, 45(1), 13-23.  
Moore, C., Murphy, M. M., Keast, D. R., & Holick, M. F. (2004). Vitamin D intake in the united 
states. Journal of the American Dietetic Association, 104(6), 980-983. doi:DOI: 
10.1016/j.jada.2004.03.028  
Moore, C., Murphy, M. M., Keast, D. R., & Holick, M. F. (2004). Vitamin D intake in the united 
states. Journal of the American Dietetic Association, 104(6), 980-983. doi:DOI: 
10.1016/j.jada.2004.03.028  
Neer RM, Arnaud CD, Zanchetta JR, & et al. (2001). Effect of parathyroid hormone (1-34) on 
fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J 
Med, 1, 1434-1441.  
Nielsen, S. J., & Popkin, B. M. (2004). Changes in beverage intake between 1977 and 2001. 
American Journal of Preventive Medicine, 27(3), 205-210. doi:DOI: 
10.1016/j.amepre.2004.05.005  
Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, & Flegal KM. (2006). Prevalence of 
overweight and obesity in the united states, 1999-2004. JAMA, 13, 1549-1555.  
Ogden CL, Carroll MD, & Flegal KM. (2008). Highbody mass index for age among US children and 
adolescents, 2003–2006. JAMA, , 2401-2405.  
  
 
Raitakan, O. T., Porkka, K. V. K., Taimela, S., Telama, R., Räsänen, L., & Vllkari, J. S. (1994). 
Effects of persistent physical activity and inactivity on coronary risk factors in children and 
young adults the cardiovascular risk in young finns study. American Journal of 
Epidemiology, 140(3), 195-205.  
Ruiz, J. C., Mandel, C., & Garabedian, M. (1995). Influence of spontaneous calcium intake and 
physical exercise on the vertebral and femoral bone mineral density of children and 
adolescents. Journal of Bone and Mineral Research, 10(5), 675-682. 
doi:10.1002/jbmr.5650100502  
Rutherford, O. M. (1999). Is there a role for exercise in the prevention of osteoporotic 
fractures? British Journal of Sports Medicine, 33(6), 378-386. doi:10.1136/bjsm.33.6.378  
Sareen G, Smith J, Groff J. (2007). Advanced nutrition and human metabolism fourth 
edition.4th, 380-387.  
Scacchi, M., Pincelli, A. I., & Cavagnini, F. (1999). Growth hormone in obesity. International 
Journal of Obesity & Related Metabolic Disorders, 23(3), 260.   
Schepper, J. D., Van den Broeck, M., & Jonckheer, M. (1995). Study of lumbar spine bone 
mineral density in obese children. Acta Pædiatrica, 84(3), 313-315. doi:10.1111/j.1651-
2227.1995.tb13635.x  
  
 
Slemenda, C. W., Miller, J. Z., Hui, S. L., Reister, T. K., & Johnston, C. C. (1991). Role of physical 
activity in the development of skeletal mass in children. Journal of Bone and Mineral 
Research, 6(11), 1227-1233. doi:10.1002/jbmr.5650061113  
Slemenda, C. W., Miller, J. Z., Hui, S. L., Reister, T. K., & Johnston, C. C. (1991). Role of physical 
activity in the development of skeletal mass in children. Journal of Bone and Mineral 
Research, 6(11), 1227-1233. doi:10.1002/jbmr.5650061113  
Specker, B. L. (1996). Evidence for an interaction between calcium intake and physical activity 
on changes in bone mineral density. Journal of Bone and Mineral Research, 11(10), 1539-
1544. doi:10.1002/jbmr.5650111022  
Spencer, E.M., Liu, CC., Si, E.C.C., and Howard, G.A. (1991). In vivo actions of insulin-like growth 
factor- 1 (IGF-I) on bone formation and resorption in rats. Bone, 1(12), 21-26.  
Thorsen K, Kristoffersson A, Hultdin J, & Lorentzon R. (1997). Effects of moderate endurance 
exercise on calcium, parathyroid hormone, and markers of bone metabolism in young 
women. Calcified Tissue International, 60, 16-20.  
Trends of obesity and underweight in older children and adolescents in the united states, brazil, 
china, and russia. (2002). Am J Clin Nutr., 75, 971-977.  
Weaver, C., & Plawecki, K. (1994). Dietary calcium: Adequacy of a vegetarian diet. The American 
Journal of Clinical Nutrition, 59(5), 1238S-1241S.  
  
 
Wuster C, Blum WF, Schlemilch S, et al. (1993). Decreased serum levels of insulin-like growth 
factors and IGF binding protein 3 in osteoporosis. J Intern Med, 1, 234-279-255.  
WÜSTER, C., BLUM, W. F., SCHLEMILCH, S., RANKE, M. B., & ZIEGLER, R. (1993). Decreased 
serum levels of insulin-like growth factors and IGF binding protein 3 in osteoporosis. 
Journal of Internal Medicine, 234(3), 249-255. doi:10.1111/j.1365-2796.1993.tb00740.x  
Yakar S, Rosen CJ, Beamer WG, Ackert-Bicknell CL, Wu Y, Liu JL, Ooi GT, Setser J, Frystyk J, 
Boisclair YR, LeRoith D. (2002). Circulating levels of IGF-1 directly regulate bone growth and 
density. J Clin Invest, 110, 771-781.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
APPENDIX A: IRB Approval 
 
  
 
APPENDIX B: Informed Consent Form 
         INFORMED CONSENT 
 
Principal Investigator: Robert C. Hickner, Ph.D. 
Institution: Human Performance Laboratory 
Address: 371 Ward Sports Medicine Building 
Telephone Number: (252) 328-4677 
 
TITLE OF PROJECT:  Reduction in CVD risk in children through physical activity 
 
INTRODUCTION 
Your child has been asked to participate in a research study being conducted by Robert C. 
Hickner and colleagues.  This research is designed to determine the effect of physical activity on 
cardiovascular disease risk in children. 
 
We will study lean and overweight preadolescent children.  Studies will take place in the Human 
Performance Laboratory of East Carolina University and in Minges Coliseum. 
 
PLAN AND PROCEDURES 
Prior to testing, you, as a guardian(s) will read and sign this Informed Consent for research, as 
well as fill out a medical history questionnaire pertaining to your child.   
 
Your child’s participation will involve: 
 
 You will fill out a personal history form that pertains to your child.  Your child will fill 
out forms  consisting of a youth risk behavior survey, leisure time exercise questionnaire, a 
personal history form, a medical form, a 30-day physical activity recall, pediatric quality of 
life inventory, and a physical self-perception profile and children’s attraction toward physical 
activity scale 
 
 Determination of body composition using body mass index (BMI), waist-to-hip ratio 
(WHR), skinfolds, and a DEXA Scan will be conducted at the Human Performance 
Laboratory.  To calculate BMI, height and weight will be measured.  Circumference 
measures will be taken at the waist and hip to calculate WHR.  Finally, skinfold thickness of 
the tricep, subscapular (shoulder blade), abdomen, thigh, suprailium (hip bone), and calf will 
be taken on the right side of the body, in duplicate, with a skinfold caliper.  Your child will 
undergo a test of body composition called a DEXA scan.  It is like an x-ray of your entire 
body.  During this test your child will be asked to wear minimal clothing (e.g., swimsuit, or 
shorts and a shirt, or a gown), and to remove all jewelry.  He/she will lie still on a padded 
table for the length of the scan (approximately 6 minutes).  The table will move across and up 
and down to scan his/her body.  Your child will not feel anything and can breathe normally 
during the scan.  If your child has metal in his/her body, then your child will not be able to 
participate in the DEXA scan.  Radiation exposure from a DEXA scan is approximately 0.04 
mrem.  The effective radiation exposure that your child would receive in this study is less 
  
 
than 0.6% of the radiation exposure an individual receives from natural background sources 
in one year.  
 Determination of Aerobic Capacity  
Two maximal treadmill tests will be completed to evaluate initial aerobic capacity. Two tests 
will be performed to assure that there is adequate effort by the children during the maximal 
treadmill test and to determine day-to-day variability in the test. If these two tests are not 
very similar, a third test may need to be conducted, so it is important that your child put out a 
maximal effort for this test. For this test, your child will walk or run on a treadmill for 
approximately 10-15 minutes. During this test, your child will wear a mouthpiece so the air 
they breathe out can be collected for analysis of oxygen. At first, your child will walk 
leisurely on the level treadmill, but the speed and level of hill climbing will become harder 
until your child can no longer continue. 
 
You will be asked to complete the n-3 FFQ at baseline, 4 weeks, 8 weeks, 12 weeks, and 16 
weeks.  This will allow us to determine 1) what your child eats over time and 2) seasonal 
variations in your childs age group and population.   
 
 Your child will complete a 3 or 4 day food record at baseline (before microdialysis), 4 weeks, 
8 weeks, 12 weeks and 16 weeks. 
 
 Your child will wear a physical activity monitor (RT3 Triaxial Accelerometer) and a 
pedometer (Yamax, Japan) five days prior to microdialysis and during the microdialysis 
portion of the study.  Additionally, your child will wear the accelerometer and  pedometer for 
3 days at 4 weeks, 8 weeks, and 12 weeks. 
 
 A fasting blood sample will be obtained from an arm or hand vein.  This will involve one to 
three small needle sticks. The procedure will take place in the Human Performance 
Laboratory. 
 
 Your child will be given a cotton swab to test for salivary cortisol levels and will be 
instructed to chew on it for 45-60 seconds.  Samples will be collected at 7 a.m. (fasting), 1:45 
(prior to a standardized 2 p.m. lunch), and 30, 45, and 60 minutes after lunch.  Additional 
samples will be collected every hour on the hour from 9 a.m. to 3 p.m.  The collection of 
samples will take place in the Human Performance Lab. 
 
 At the Human Performance Lab, the insertion of up to three small probes to determine 
glycerol levels and rates of lipolysis will take place.  This probe, called a microdialysis 
probe, is a small flexible piece of plastic tubing (about an inch long and the width of a 
needle) that is inserted through the skin, and then through the subcutaneous fat about 1/8 to 
1/4 inch below the skin of the stomach.  First, to numb the area of insertion, a topical cold 
spray (ethyl chloride) or a numbing creme (Emla creme) will be applied to the skin.  A 
needle surrounded by plastic tubing will be inserted into the subcutaneous fat of your child’s 
stomach.  The needle will be taken out of the fat and replaced with the small piece of tubing.  
The tubing will not be located in a blood vessel but between fat cells.  A Ringer solution (a 
  
 
saline/salt-water solution) will be pumped through the piece of tubing to monitor blood flow 
and fat break down in the fat tissue.  The pumped fluid will be harmless to your child since it 
is similar to the fluid already present between the cells of the body.  The Ringer solution will 
be pumped at a rate of no more than 5 microliters per minute (equivalent to a very tiny drop).  
Your child will not feel the presence or effects of this solution.  Samples will be collected 
every hour while your child is at ECU and at home for the remainder of that day until the 
following morning. Only one overnight sample will be collected when your child wakes up 
the following morning. 
 
 After the microdialysis pump is set up, your child will participate in activities pre-planned 
and provided by the study investigators.  Activities will take place in Minges Coliseum.  
Possible activities will include walking on a treadmill, riding a stationary cycle ergometer, 
roller-skating, and jump roping.  Other activities will include watching movies and playing 
board games.  All activities will be monitored by a trained exercise physiologist who is 
familiar with the usage and safety precautions for each activity.  By no means will your child 
be limited in what he/she can do during the day, except for activities that involve rough 
physical contact (for example, football). 
 
    The full day monitoring will take place on a day that the child is already out of school 
      (i.e. vacation, weekend). 
 
 If your child is randomized (similar to picking groups by flipping a coin) to the 16-week 
physical activity program, he/she will undergo all testing described above (preliminary 
measurements and a separate visit of approximately 8 hours for microdialysis in the lab) 
before and after the 16 week program. If your child is randomized to the control group that 
does not participate in the 16 week physical activity program, they will be required to 
undergo only the preliminary measurements and another visit (microdialysis) of 
approximately 8 hours in the lab.    
                                                             
RISKS AND DISCOMFORTS 
There are certain risks and discomforts that may be associated with this research.  They include: 
 
 The total amount of blood drawn for fasting blood draw is negligible.  There is an extremely 
small risk of local hematoma or infection associated with the needle stick. 
 
 Insertion of the microdialysis probe is associated with mild discomfort, similar to that 
experienced during an intramuscular injection.  Your child will not feel discomfort from the 
substances (for example, Ringer solution) pumped through the microdialysis probe.  Risks 
associated with this procedure are small, and include hematoma (swelling and bruising) and 
infection.  To minimize the risk of hematoma or infection associated with the insertion of the 
microdialysis probes into the subcutaneous adipose tissue, these procedures will be 
performed using sterile techniques. The probes are also made of biocompatible materials. 
 
 There are some risks associated with physical activity such as bumps, bruising, scrapes and 
other injuries associated with active children. 
  
 
 
 Risks associated with the maximal exercise are dizziness, ventricular arrhythmia (odd 
heart beats), and in very rare instances death. These risks are very small, with an 
incidence of fewer than 1 in 10,000 deaths in patients who are known to, or suspected of, 
having heart disease. The risk is expectedly much smaller than this in a group of young, 
healthy subjects. To further minimize the risk, faculty and students that have been 
extensively trained in administering maximal exercise tests will administer the 
assessments. If during a test a subject complains of dizziness, chest discomfort or other 
signs of exercise intolerance, the test will be promptly stopped. In the event of loss of 
consciousness, breathing or heart beat, appropriate CPR and AED administration will be 
initiated and Greenville Fire/Rescue will be notified via 911.  
 
 Risks of the body composition assessment are those associated with exposure to low 
levels of radiation. Risks will be minimized by using an FDA-approved bone density 
machine (Prodigy, GE Lunar Corp., Madison, WI). This procedure involves a minimal 
amount of radiation. 1-3 microSieverts) that is within an acceptable range as provided by 
“North Carolina Regulations for Protection Against Radiation”.  The amount of radiation 
(1-3 microSieverts) exposure of one procedure is quite minimal.  For example, radiation 
exposure is approximately 80 microSieverts on a transatlantic airline flight of 8 hours, 50 
microSieverts living in Denver, Colorado, at an elevation of 5,000 feet for approximately 
4 weeks, or 30 to 40 microSieverts during a typical chest x-ray. There is a potential risk 
to unborn children for those who are pregnant; therefore, pregnant women must not 
undergo this procedure.  
 
 
 Your child should be aware that there are unforeseen risks involved with this and all 
research studies. 
 
POTENTIAL BENEFITS 
Subjects will be able to participate in supervised physical activity and games. The risks are 
minimal relative to these benefits and the benefits of gaining knowledge with respect to the role 
of cortisol in childhood obesity. 
 
TERMINATION OF PARTICIPATION 
Your child’s participation in this research study may be terminated without your consent if the 
investigators believe that these procedures will pose unnecessary risk to your child.  Your child 
may also be terminated from the participation if your child does not adhere to the study protocol. 
 
COST AND COMPENSATION 
Your child will be paid $50.00 as well as prizes worth $25 for his/her time and inconvenience for 
completion of each microdialysis procedure.  Each family with child/children in the exercise 
group will be compensated $40 for transportation related expenses at 8 weeks. 
The policy of East Carolina University does not provide for the compensation or medical 
treatment for subjects because of the physical or other injury resulting from this research activity.  
  
 
However, every effort will be made to make the facilities of Brody School of Medicine, Pitt 
County Memorial Hospital available for treatment in the event of such physical injury. 
 
CONFIDENTIALITY 
Only the investigators associated with this study will have access to the data obtained.  No 
identifying information will be released.  Numeric coding, which only the primary investigator 
will have access to, will protect the identity of your child and other subjects.  Data will be 
secured in a locked filing cabinet in the office of the primary investigator in the Human 
Performance Laboratory.  The data will be kept for 7 years.  Samples will be stored in freezers at 
the Human Performance Laboratory for a maximum of 7 years.  Your child can request 
destruction (discarded into biohazard containers and disposed of by ECU biohazard personnel) of 
his/her samples at any time.   
 
VOLUNTARY PARTICIPATION 
Your child understands that his/her participation in this study is voluntary.  Refusal to participate 
will involve no penalty or loss of benefits to which your child is otherwise entitled.  Furthermore, 
your child may stop participating at any time he/she chooses without penalty, loss of benefits, or 
without jeopardizing his/her continuing medical care at this institution. 
 
RESEARCH PARTICIPANT AUTHORIZATION TO USE AND DISCLOSE 
INFORMATION 
Federal laws require that researchers and health care providers protect your identifiable health 
information.  Federal laws also require that researchers get your permission to use collected 
health information for research.  The identifiable information we will collect from subjects in 
this research project will include:   
*General Medical History including: Family health history, medications, nutrition, physical 
activity levels and body weight history. 
*Body composition information, adipose tissue blood flow and metabolism, blood levels of 
insulin, glucose, free fatty acids, and other compounds related to cardiovascular disease risk. 
 
The members of our research team that will have access to your information will include the 
Principle investigator, co-investigators, as well as technical and nursing personnel involved in 
this project.  Information about you will be used and released in such a way that will protect your 
identity as much as possible; however, confidentiality cannot be absolutely guaranteed.  We will 
only share your information with those individuals listed above.  If we need to share information 
with other individuals other than those listed, we will request your permission a second time.   
You will be given a signed copy of your authorization to release medical information for 
your records.  You can limit the amount and type of information that is shared and you must 
make this request in writing; however, the researcher is able to use any and all information 
collected prior to the request not to disclose information.  Although you can limit the release of 
your medical information, withholding some information may cause you to become ineligible for 
this research project.  Because research information continues to be looked at after a study is 
finished, it is difficult to say when the use of your information will stop.  There is currently not 
an expiration date for the use and disclosure of your information for this study. 
 
 
  
 
PERSONS TO CONTACT WITH QUESTIONS 
If you have questions related to the sharing of information, please call Robert Hickner at 252-
737-4677 (days) or 252-353-5556 nights or weekends or Joseph Garry, M.D. at 744-1953 (days) 
or 353-2825 (nights and weekends).  You may also telephone the University and Medical Center 
Institutional Review Board at 252-744-2914.  In addition, if you have concerns about 
confidentiality and privacy rights, you may phone the Privacy Officer at Pitt County Memorial 
Hospital at 252-847-6545 or at East Carolina University at 252-744-2030. 
 
CONSENT TO PARTICIPATE 
Your child certifies that he/she has read all of the above information, asked questions, and 
received answers concerning areas he/she did not understand, and have received satisfactory 
answers to these questions.  Your child willingly consents for participation in this research study.  
(A copy of this consent form will be given to the person signing as the subject or as the subject’s 
authorized representative.) 
 
Participant’s Name (Print) 
 
 
Authorized Representative’s Name (Print) – Guardian #1                                                
 
 
Signature of Authorized Representative – Guardian #1     Date                                    
 
 
Authorized Representative’s Name (Print) – Guardian #2                                                 
 
 
Signature of Authorized Representative - Guardian #2                       Date 
 
 
AUDITOR WITNESS:  I confirm that the contents of this consent/assent form were orally 
presented. 
 
Auditor’s Name (Print) 
 
 
Signature of Auditor                                                                         Date 
 
 
Principal Investigator’s Name (Print) 
 
 
Signature of Principal Investigator                                                    Date    
  
 
FUTURE TESTING OF BLOOD/MICRODIALYSIS SAMPLES 
Upon termination of this study, the blood and urine samples collected for this study will be 
stored for up to 10 years to research scientific questions specifically related to cardiovascular 
disease risk in children. I will continue to be the owner of the samples and retain the right to 
have the sample material destroyed at any time during this study by contacting the study 
principal investigator. During this study the samples will be stored with number identifiers only; 
however, the number identifier will be linked to a specific name and will be kept on file in the 
possession of the principal investigator. The linked file will be stored password protected on the 
Principal Investigator’s computer with CD backup. No other individuals will have access to 
these identifying materials unless the principal investigator is required by law to provide such 
identifying information. Data will not be publicly available and participants will not be 
identified or linked to the samples in publication. If a commercial product is developed from this 
research project, I will not profit financially from such a product. 
 
CONSENT TO PARTICIPATE IN FUTURE TESTING OF BLOOD SAMPLES  
 
I certify that I have read all of the above, asked questions and received answers concerning areas 
I did not understand, and have received satisfactory answers to these questions. I willingly give 
my consent for participation in this research study.  (A copy of this consent form will be given to 
the person signing as the subject or as the subject’s authorized representative.) 
 
CONSENT TO PARTICIPATE 
Your child certifies that he/she has read all of the above information, asked questions, and 
received answers concerning areas he/she did not understand, and have received satisfactory 
answers to these questions.  Your child willingly consents for participation in this research study.  
(A copy of this consent will be given to the person signing as the subject or as the subject’s 
authorized representative.) 
 
 
Participant’s Name (Print) 
 
Authorized Representative’s Name (Print) – Guardian #1                                                
 
Signature of Authorized Representative – Guardian #1     Date                                    
 
Authorized Representative’s Name (Print) – Guardian #2                                                 
 
Signature of Authorized Representative - Guardian #2                       Date 
 
AUDITOR WITNESS:  I confirm that the contents of this consent/assent form were orally 
presented. 
 
Auditor’s Name (Print) 
 
  
 
Signature of Auditor                                                                         Date 
 
Principal Investigator’s Name (Print) 
 
Signature of Principal Investigator                                                    Date    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
APPENDIX C: Minor Assent Form 
             ASSENT DOCUMENT FOR CHILDREN 
Principal Investigator: Robert C. Hickner, Ph.D. 
Institution: Human Performance Laboratory. 371 Ward Sports Medicine Building 
Telephone Number: (252) 737-4677 
TITLE OF PROJECT: Reduction in CVD risk in children through physical activity 
You have been asked by Dr. Robert Hickner and workers in the Human Performance Lab to be 
part of a research project at East Carolina University.  In this project, you will do several 
different things.  
  
1. You will fill out forms about physical activity habits, including forms consisting of a youth 
risk behavior survey, leisure time exercise questionnaire, a medical form, a 30-day 
physical activity recall, HPCS, MSPCS, pediatric quality of life inventory, and a physical 
self-perception profile and children’s attraction toward physical activity scale 
 
2.  You will have your height, weight, and skinfolds and percent body fat measured.           
Skinfolds are  
measured by pinching different areas of fat on your body.  You may feel a very light 
pinch.  You will then go to another room where we will do a test called a DEXA Scan.  It 
is like an x-ray of your entire body.  During this test you will wear shorts and a shirt, or a 
gown, and you will take off any jewelry.  You will then lie still on a padded table for 
about 6 minutes.  The table will move across and up and down to scan your body, but you 
do not feel anything and can breathe normally during the scan.   
 
3.  You will come to the Human Performance Lab for a day (7 a.m. to 3 p.m.), where you     
will be able to play fun games, watch movies, and make new friends.   
 
4.   Someone at the lab will draw blood from a vein in your arm or hand. The needle stick 
will only hurt for a few seconds, although we may need to try up to three times if we do not 
get the blood on our first try.  
 
5.  You will have a small needle put into the fat under the skin of your stomach.  You may 
feel a slight sting, but Dr. Hickner will try to make sure that this hurts as little as possible by  
      spraying a cold spray or putting a cream on your stomach to numb your skin.  A small  
      plastic tube (as thin as a piece of thread) will be put through this needle under your skin.  
The needle will then be taken out after the plastic tube is in place. The plastic tube will 
then be hooked up to a little pump (smaller than a Walkman). You will have three of 
these needle sticks and plastic tubes put under the skin of the stomach. A liquid, called 
Ringer’s solution, will be pumped through the plastic tubes.  This solution will help 
measure the break down of fat in your tissue. You will wear the pump on a belt while you 
are at ECU and while you are at home on this day until the next morning. You will have 
this test done before and after the 16-week physical activity program. 
  
 
 
6.  You will wear activity monitors, which looks like a pager, for 5 days prior to the day visit, 
and during the day visit.  Additionally, you will wear the activity for 3 days during weeks 
4, 8, and 12.  You will 
wear the monitors on your belt or clothes. 
 
7.   You will participate in a maximal exercise test on the treadmill. For this test, you will 
walk or run on a treadmill for approximately 10-15 minutes. During this test, you will 
wear a mouthpiece so the air you breathe out can be collected. At first, you will walk on 
the level treadmill, but the speed and level of hill climbing will become harder until you 
can no longer continue. You will go through this test on two separate days. If these two 
tests are not very similar, a third test may be needed, so it is important that you put out 
a maximal effort for this test. 
 
8. You will participate in a 16-week physical activity program where you will skate, ride 
bicycles, and play active games. You will need to come to the activity center 3 to 4 times 
per week for at least one hour per time. 
9. You will be asked to drink a mixture of an amino acid (a component of protein that is 
found in many foods) and fruit juice before you go to bed.  After this, you will be asked 
to collect your urine in a plastic container for the next 10 hours (each time you wake up).  
You will be asked to do this at start of the study, after 8 weeks of the activity program 
and at the end (approximately 16 weeks) of the study.  
        
10. On a separate day, you will be asked to collect your urine in a jug we provide to you for a 
24 hour period.  This will occur at the start of the study, after 8 weeks of the activity 
program and at the end of the study.  You will write down everything you eat or drink on 
the day in which you collect your urine.  
 
11. You will be asked to complete a 3 or 4 day food records at baseline (before 
microdialysis), 4 weeks, 8 weeks, 12 weeks and 16 weeks.   
 
12.  Your personal information and samples collected will be kept private and safe in the 
Human Performance Lab. Only Dr. Hickner and co-workers will have access to your data. If 
you decide that you want you samples thrown out, your samples will be gotten rid of 
properly by workers at ECU. 
 
 
 Child's Name  (print)                                                                        (Date)          
 
 
 Child's signature                                                                         (Date)          
  
 
 
PERSONS TO CONTACT WITH QUESTIONS 
The investigators will be available to answer your (or your guardian’s) questions concerning this 
research, now or in the future.  You or your guardian(s) may contact the investigators, Robert 
Hickner, Ph.D. at 737-4677 (days) or Joseph Garry, M.D. at 744-1953 (days) or 353-2825 
(nights and weekends).  Also, if questions arise about your rights as a research subject, you or 
your guardian(s) may contact the Chairman of the University and Medical Center Institutional 
Review Board at 252-744-2914 (days). 
 
CONSENT TO PARTICIPATE 
You certify that you have read all of the above information, asked questions, and received 
answers concerning areas you did not understand, and have received satisfactory answers to 
these questions.  You willingly consent for participation in this research study.  (A copy of this 
consent form will be given to the person signing as the subject or as the subject’s authorized 
representative.) 
 
 
Authorized Representative Name (Print) – Guardian #1                                               
 
Signature of Authorized Representative – Guardian #1          Date 
 
Authorized Representative Name (Print) – Guardian #2                                                 
 
Signature of Authorized Representative – Guardian #2                  Date 
 
AUDITOR WITNESS:  I confirm that the contents of this consent/assent form were orally 
presented. 
 
Objective Third Party Witness Name (Print) 
 
Signature of Objective Third Party Witness         Date 
 
Principal Investigator’s Name (Print) 
 
Signature of Principal Investigator                                                                                         Date    
 
 
 
 
 
  
 
APPENDIX D: 3 DAY DIET LOG 
 
  
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
  
 
APPENDIX E: ACTIVITY MONITORING LOG 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
